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Treatment of International Research and Development as Investment: 
Issues and Estimates 
Bureau of Economic Analysis/National Science Foundation 
R&D Satellite Account Background Paper 
By Daniel R. Yorgason 
 
In recent years, the Bureau of Economic Analysis (BEA) has initiated a long-term 
effort to provide more extensive economic data and analysis about research and 
development (R&D) activity and its effects on the economy.  A major part of this effort 
has been the development, in conjunction with the National Science Foundation (NSF), 
of the R&D satellite account (R&DSA), a project that examines the effects on BEA’s 
economic accounts of capitalizing R&D, that is, treating the knowledge created by R&D 
as a long-lived, intangible asset that contributes to future production in much the same 
manner as physical (tangible) capital.  Under such an approach, spending on R&D is 
treated as investment, rather than as an expense as is current practice in BEA’s accounts.
1  
The R&DSA was first released last year.  Revised and extended estimates—the 2007 
R&DSA—have been released recently.
2  This paper, although not wholly integrated with 
the central R&DSA work, is related to that work.  Its purpose is to examine various 
international aspects of the R&DSA and, more generally, the effects of treating R&D as 
investment throughout BEA’s international accounts.  This paper and one on regional 
effects constitute 2007 R&DSA background papers. 
                                                 
1 The phrase  “treat R&D as investment” (or variations of that term) is used 
throughout this paper.  Somewhat less frequently used is the phrase “capitalize R&D” (or 
variations).  These are used synonymously. 
2 BEA has other satellite accounts besides the R&DSA.  The 2007 release of the 
R&DSA, accompanied by a full report and an appendix,  is accessible on BEA’s website 
at <http://www.bea.gov/newsreleases/general/rd/2007/rdspend07.htm>.  (The 2006 
R&DSA, available in full at 
<http://www.bea.gov/newsreleases/general/rd/rdspend06.htm>, is also discussed in a 
SURVEY OF CURRENT BUSINESS article:  Okubo, et. al (2006).) 
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The 2006 R&DSA focused on the effect of treating R&D as investment on GDP 
and other aggregate measures of economic activity.  While some of the work on the 2007 
account has been devoted to updating and improving these aggregate estimates, a 
substantial amount of work has been devoted to extending the methodology and estimates 
to an industry level.  In addition, the 2007 effort takes an initial look at the possibilities 
and implications of extending R&D capitalization to regional and international accounts 
(and related data).  Work on the regional and international areas will shed light on 
potential approaches to be taken, and issues to be confronted, in future extension of the 
R&DSA work in these two directions. 
Broadly, this paper discusses the international aspects of the R&DSA and the 
prospects for, and possible effects of, treating international R&D as investment, both in 
the data that enter the international transactions accounts (ITAs) and international 
investment position (IIP), and in the data on multinational-company operations collected 
by BEA.  Specifically, it notes the incorporation of estimates of trade in R&D services 
into the central (domestic) R&DSA; it provides estimates (that are not used in the central 
R&DSA) of R&D capital held by multinational companies (MNCs); and it applies those 
to adjust estimates of direct investment income flows (and, in turn, estimates of 
international investment income and current account flows) and the direct investment 
position (and, in turn, the international investment position).  It also discusses certain 
R&D-associated activities that have not been incorporated into the quantitative analysis, 
including trade in R&D-generated intangible assets and spillovers of R&D-generated 
knowledge. 
In analyzing the international aspects of treating R&D as investment, the paper 
addresses a variety of issues—some conceptual, others practical.  Conceptual issues focus 
on the extent to which the goal of treating R&D as investment is yet a well-defined goal, 
one that might produce straightforward, informative estimates.  Practical issues focus 
particularly on BEA’s capability to produce such estimates at a sufficiently high level of 
precision with its existing resources and data programs.  The paper also provides a first-
pass set of estimates in which potential ways of dealing with some of the conceptual and 
practical issues are illustrated.  These are rough, aggregate-level “order-of-magnitude” 
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estimates that quantify the effects of treating R&D as investment on key international 
data series.  Throughout, the paper endeavors to maintain consistency with the basic 
approach to the treatment of R&D as investment taken in the central R&DSA work.  In 
particular, estimates of international R&D capital stocks are generated using the perpetual 
inventory method.  Changes in the R&D capital stock value are (roughly) R&D 
investment flows less R&D depreciation.  Depreciation, like the underlying capital stock, 
must be estimated, as direct data are not collected.  A time series of capital stock 
estimates is constructed recursively from a time series of investment estimates. 
The paper consists of several sections.  Discussion of both the practical issues 
and, to a lesser extent, the conceptual issues requires context.  Consequently, the first 
section following this introduction, section I, identifies the types and sources of 
international data collected and/or published by BEA that are relevant to the R&D 
capitalization project.  Magnitudes of selected data are also presented to give a sense of 
the scale of R&D relative to other related activities.  Next, section II discusses a selection 
of major R&D-related conceptual issues—such as joint ownership of knowledge capital 
within MNCs (from which arises the problem that the measurement domain fails to 
encompass the relevant ownership unit), knowledge spillovers, and net entry of firms into 
the direct investment universe—particularly important in, but typically not unique to, the 
international dimension.  Practical data issues specific to the R&D-associated data 
collected by BEA and to the other key series potentially affected by a change in treatment 
of R&D are then discussed in section III.  That section also discusses ways these data 
collections might be supplemented.  Section IV, the longest section, discusses the 
methodology and assumptions used to generate the order-of-magnitude estimates, after 
which it presents those estimates.  Section V summarizes the paper and discusses possible 
directions for future development of work treating R&D as investment in the 
international accounts and other BEA international data. 
The order-of-magnitude estimates—which are computed in current dollars, not 
constant dollars—suggest that the effects of treating R&D as investment on total capital 
stocks and value added of MNCs would not be inconsequential.  Smaller effects would be 
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seen for the series entering the international accounts.  Highlights of the effects of 
treating R&D as investment include: 
•  The current-account deficit falls by $1.3 billion, or 0.2 percent, in 2004 as 
direct income receipts rise more than direct income payments.  The $1.3 
billion change generates larger relative effects for other, lower-level 
balances: the surplus on direct investment income rises by 0.9 percent, and 
the surplus on total international investment income rises by 2.3 percent. 
•  The 2004 outward direct investment position rises by $125.0 billion, or 5.1 
percent, and the inward direct investment position rises by $149.2 billion, 
or 8.6 percent.  The net (outward minus inward) direct investment 
position—currently estimated to be a positive value—falls by $24.2 
billion, or 3.2 percent.  The $24.2 billion change causes the net 
international investment position—which includes both direct and other 
types of investment, and is currently estimated to be a negative value—to 
rise (i.e., become more negative) by 1.1 percent.. 
•  The 2004 value added of majority-owned foreign affiliates of U.S. MNCs 
rises by $25.9 billion, or 3.1 percent, with R&D treated as investment.  
The relative increase in the value added of U.S. and foreign MNCs located 
in the United States—which together account for four-fifths of U.S. 
R&D—is larger:  for majority-owned U.S. affiliates of foreign MNCs 
value added rises by $28.l billion, or 5.5 percent; for U.S. parent 
companies, value added rises by $148.2 billion, or 6.7 percent. 
It is widely recognized that MNCs play a major role in the creation of “knowledge 
capital” and in the international dissemination of technology and “know how.”  However, 
gauging the impact of these activities on the economies of the United States and other 
countries presents challenging measurement issues—in particular, the identification and 
classification of knowledge sharing (or joint ownership of knowledge) within MNCs.  A 
major goal of this paper—one that is intended to spotlight and augment understanding of 
some of these issues—is to examine how the treatment of the R&D of MNCs as 
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investment would impact the measurement of the international dimension in the U.S. 
economic accounts. 
The paper presumes a certain familiarity with the  R&DSA and its associated 
goals and methods.  It does define and provide context for the key issues discussed, but 
some details are ignored when not vital to the discussion (or some issues are glossed over 
altogether) that receive more extensive treatment in that report.  In addition, for 
simplicity, the phrase “international R&D data” will be used in this paper to denote data 
on R&D that is connected in some manner to BEA’s international accounts.  These 
international R&D data are discussed next. 
 
I.  Types of international R&D data 
This section identifies the main types and sources of R&D data currently available 
to BEA’s international program in preparation for discussions in subsequent sections of 
how such R&D can best be treated as investment (capitalized).  It also identifies other 
estimates published by the international program for which a switch from R&D 
expensing to capitalization would have important implications.  Besides identifying data, 
the section touches, at a very broad level, on possible approaches to estimating the effects 
of capitalization.  In addition, it compares a few published estimates of R&D to related 
data to give a sense of the magnitude of the international R&D data. 
BEA’s international accounts include the ITAs, the IIP, and collections of 
estimates of the finances and operations of MNCs.  In principle, a switch from expensing 
to capitalizing R&D would affect several key data series in the ITAs through its effect on 
income calculations.  It would affect the stock series in the IIP by adding a new class of 
assets to direct investment holdings.  Treating R&D as investment would also affect 
several items in the MNC-operations estimates.  However, unlike the primary sources for 
the ITAs and IIP, source data for the MNC- operations estimates do include information 
on R&D expenditures.  These expenditure data permit the computation of the effects of 
the treatment of R&D as investment, not only for the operations estimates themselves, 
but also for the ITAs and IIP. 
  5   October  2007 
 
Although the three basic types of international accounts are the ITAs, the IIP, and 
the MNC operations data, it is convenient to categorize the international data somewhat 
differently for the purpose of discussing R&D capitalization.  In this alternative 
categorization, international R&D data are assigned to one of three categories:  A) 
international trade, B) international investment income and position, and C) operations of 
MNCs.  The first is a subset of the ITAs.  The second is a another (separate) subset of the 
ITAs, combined with the IIP.  These categories are briefly described below, along with a 
discussion of the extent to which relevant data are available to BEA. 
A)  International trade data 
Direct R&D-associated transactions between a party in the United States and a 
party outside the United States are considered international trade in R&D, and are 
included in the ITAs as trade in services.  Treating R&D as investment does not affect the 
trade balance or the value of exports and imports, as whether R&D is treated as 
investment or as an expense does not affect how its trade is recorded.  However, 
recognition of international trade in R&D does affect domestic measures of R&D 
investment and capital.  If these transactions represent the flow of long-lived assets, then 
given the volume of R&D, recognizing exports of R&D reduces measured domestic 
R&D investment and capital stock and recognizing imports of R&D increases these two 
measures. 
The international trade data category includes two conceptually distinct types of 
R&D-associated international transactions—trade in R&D services and trade in those 
intangible assets resulting from R&D.
3  Data on trade in R&D services measures the 
transactions value of R&D activity performed by one entity on behalf of another entity 
                                                 
3 To a certain extent trade in R&D services can be thought of as trade in R&D 
inputs, and trade in intangible assets can be thought of as trade in R&D outputs.  
However, this distinction is not necessarily iron-clad.  For instance, one firm might 
contract to have another perform R&D on its behalf.  The contract might connect 
payment with the performing firm’s expenditures, whether or not the R&D ultimately 
proves to be of benefit to the funding firm.  Or, the contract may arrange for payment 
only to the extent that certain pre-specified outcomes are realized.  The contract might 
also be a combination of these two possibilities, with some remuneration for the 
performing firm’s efforts/inputs, but with additional incentives for meeting output targets. 
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located in a different country (with one of the entities located in the United States).  
Payment for R&D services is typically contractually arranged.  In the ITAs, estimates of 
R&D services are included, but not separately identified, in the “research and 
development and testing services” category of business, professional, and technical 
services trade.  Although the testing component of this category includes services that are 
not considered R&D, it is generally thought that R&D makes up a substantial portion of 
the category’s actual trade. 
In contrast, data on trade in R&D-generated intangible assets, or R&D outputs, 
measure the transactions value of international transfers of the intangible asset 
(knowledge) resulting from previously performed R&D, often along with the associated, 
though possibly circumscribed, legal rights to use such knowledge.  Transactions of these 
sorts may be either outright sales of knowledge or other more restricted arrangements, 
such as payment for the right to use the knowledge for a specified period and/or in a 
specified context.  In the ITAs, estimates of such transactions are included within the 
broader category of royalties and license fees, a category that includes transactions of 
several types of intangible assets, several of them likely to result from processes other 
than R&D.  The intangible asset category most likely to result from R&D is denoted as 
“rights related to industrial processes and products.”
4 
BEA’s surveys of trade in international services and intangible assets request that 
transactions with affiliated persons—that is, with foreign parents, other foreign affiliates 
                                                 
4 “Rights to general use computer software” is another category in which the 
intangible assets might be the result of previous R&D activity.  However, BEA’s NIPAs 
currently treat computer software as a separate type of asset, one distinct from R&D 
capital.  Intangible assets in other categories—books, compact discs, audio tapes; 
trademarks; broadcast and recording of live events; business format franchising fees; and 
other intangibles—are less likely to derive from R&D as defined on NSF surveys and 
BEA’s surveys of MNCs, but may, in part, derive from R&D more broadly defined to 
include research in the social sciences and humanities, as suggested by the Franscati 
manual (Organisation for Economic Co-operation and Development (2002)).  The 
distinction between definitions currently used for data collection and those recommended 
in international guidelines is discussed later in the text. 
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of foreign parents, or foreign affiliates—be reported separately.
5  These surveys have 
recently been restructured and rationalized.  Prior to 2004, data on unaffiliated 
transactions were only collected annually; now they are collected quarterly.  Prior to 
2006, data on affiliated transactions were collected on separate surveys from data on 
unaffiliated transactions; starting with 2006 (2007 for quarterly data), they have been 
collected on the same survey.  Also, before 2006, data on affiliated transactions in “rights 
related to industrial processes and products” royalties and license fees were not separately 
collected, but were indistinguishably categorized with all other royalties and license fees; 
they are now distinguished just as for similar unaffiliated transactions.  Improvements to 
the surveys also occurred in earlier years.  In 2001, data on affiliated R&D and testing 
services trade began to be separately identified; previously they were included in 
affiliated business, professional, and technical services trade.
6  
In 2004, U.S. exports of R&D and testing services were $8.8 billion, 2.7 percent 
of total private services exports.
7  Receipts for rights related to industrial processes and 
products were likely substantially larger.  Estimates of these receipts, as a separate 
component of royalties and license fees, are only separately published for unaffiliated 
transactions; these were $5.7 billion.  Assuming, conservatively, that 80 percent of 
affiliated royalties and license fees receipts were for rights related to industrial processes 
and products gives $31.3 billion in such receipts, and a total of $36.9 billion for 
unaffiliated and affiliated receipts.
8  Combining the rights related to industrial processes 
                                                 
5 See appendix A for a more complete description of BEA’s surveys on 
international trade in services and intangible assets, and for the definitions used on those 
surveys for the categories of trade related to R&D. 
6 Prior to 1997, these services were included in “other private services.” 
7 Data from 2004, as opposed to some more recent year, are used to give a sense 
of the magnitude of international R&D data, as 2004 is the latest year included in the 
order-of-magnitude estimates presented later in the paper. 
8 The 80 percent assumption is conservative relative to shares from data collected 
in other (isolated) instances.  Data on affiliated transactions of rights to intangible assets 
related to industrial processes were collected in the 1989 benchmark survey of U.S. direct 
investment abroad.  In that year, such transactions accounted for 89 percent of affiliated 
royalties and license fees receipts and 93 percent of payments.  In addition, preliminary 
indications from the 2006 survey of international trade in services are that transactions of 
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and products with R&D and testing services shows that R&D-related trade accounts for 
approximately 14 percent of total private services exports. 
Imports of R&D and testing services were $5.0 billion in 2004, 1.9 percent of 
total private services imports.  Payments in unaffiliated transactions of rights related to 
industrial processes and products were $2.8 billion.  Assuming, again, that 80 percent of 
affiliated royalties and license fees payments were for rights related to industrial 
processes and products gives $14.4 billion in such payments, and a total of $36.9 billion 
for unaffiliated and affiliated payments  With the $5.0 billion in R&D and testing 
services, R&D-related imports (broadly defined) was approximately 9 percent of total 
imports of private services. 
B)  International investment income and position data 
This category consists of estimates included in the ITAs of receipts and payments 
of investment income, and outward and inward investment positions, for both portfolio 
and direct investment.  As conventionally constructed, none of these estimates make use 
of information on R&D activity.  Of the two, however, the direct investment estimates—
where income results from a full range of firms’ economic activities rather than simply 
from interest and  dividends—require adjustment to account for changes in the measure 
of income to reflect the treatment of R&D as investment.  The data used to estimate 
direct investment income and position are obtained from BEA’s quarterly surveys of 
direct transactions between parent companies and affiliates.  Lacking any information on 
R&D, as noted above, data from these surveys must be supplemented in order to account 
for the effects of treatment of R&D as investment in the income and position estimates.  
Fortunately, BEA does conduct other surveys of essentially the same group of companies 
in which information on R&D is obtained.  These other surveys are the surveys on the 
operations of MNCs, the surveys underlying the data category discussed next.  Given the 
extent of overlap of the two survey populations, using data from the operations surveys to 
                                                                                                                                                 
rights related to industrial processes and products will account for the vast bulk of 
affiliated royalties and license fees transactions when estimates from that survey are 
released. 
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supplement data from the balance of payments surveys is, conceptually, relatively 
straightforward. 
C)  Operations of MNCs 
This category includes data on expenditures for R&D either performed by or 
funded by (or both) MNCs with operations in the United States.  BEA collects R&D data 
in its surveys covering the finances and operations of U.S. MNCs and U.S. affiliates of 
foreign MNCs on a basis consistent with that used in NSF’s surveys of Industrial 
Research and Development.
9  Annual series of BEA survey data on MNCs’ R&D 
expenditures date back to 1989 for U.S. parent companies and their foreign affiliates, and 
to 1977 for U.S. affiliates.  In benchmark surveys (currently conducted once every five 
years), data are collected on both R&D performance and R&D funding.  Although both 
funding and performance data can be used as a basis for R&D investment estimates, 
funding data are preferred, as they more accurately identify the owners/beneficiaries of 
the R&D (this issue is discussed at greater length in the next section).  In annual surveys 
(conducted in non-benchmark years), R&D data were collected on a funding basis until 
1993 for outward direct investment data (i.e., for U.S. parents and foreign affiliates) and 
until 1996 for inward data (i.e., U.S. affiliates).  Since those two respective years, annual 
data have been collected on a performance basis. 
The MNCs’ operations data are not used directly in any of the ITAs or NIPAs.  
However, just as physical capital investment data from the operations surveys are now 
used to adjust direct investment income and position data from the financial accounting 
basis upon which they are collected to the economic accounting basis used for BEA’s 
published estimates, data on MNCs’ R&D expenditures could be used to adjust the 
income and position data for the effects of treating R&D as investment.  In addition, 
estimates of R&D investment and stocks derived from the operations data can themselves 
be compared to the R&D investment and stock estimates in the R&DSA.  This 
comparison would facilitate efforts to gauge the role of MNCs in U.S. R&D, and to 
                                                 
9 See appendix A for a more complete description of BEA’s surveys of the 
operations of MNCs, and for the definitions used on those surveys for the type of 
activities considered R&D. 
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compare the extent to which U.S. parents focus their R&D activities in the United States 
or spread them overseas through their foreign affiliates. 
In 2004, R&D expenditures, measured on a performance basis, were $152.4 
billion for U.S. parents (85 percent of the U.S.-MNC total) and $27.5 billion for their 
majority-owned foreign affiliates (15 percent of the total).  Performance expenditures 
were $29.9 billion for majority-owned U.S. affiliates.  On a funding basis, U.S. parent 
expenditures were $148.2 billion and foreign affiliate expenditures were $25.9 billion.  
For majority-owned U.S. affiliates of foreign companies, the performance-based 
estimates of the cost of R&D performed by those companies in 2004 was $30.1 billion.  
In 2002, the latest year for which data were collected on both bases, funding-basis 
expenditures by U.S. affiliates were 94 percent of their performance-basis expenditures, 
the same percentage as for U.S. parents in 2004.  Compared to R&D performance 
expenditures of all U.S. businesses of $208.3 billion, U.S. parents accounted for 73 
percent and majority-owned U.S. affiliates accounted for 14 percent.  Correcting for 
double counting in those instance in which a U.S. parent is also a foreign parent yields an 
estimate of 80 percent of all-U.S.-business R&D performance that was accounted by 
domestic or foreign MNCs. 
Related to the MNC operations data is a project currently getting underway 
involving BEA, NSF, and the Census Bureau (which conducts R&D surveys on behalf of 
NSF).  This project will link U.S. parent and U.S. affiliate R&D data from BEA’s surveys 
of MNC operations with data from NSF’s surveys of U.S. private industry R&D.  The 
project will provide a more complete picture of R&D associated with U.S. and foreign 
MNCs.
10  The data link will provide information on the types of R&D conducted by 
MNCs (basic research, applied research, and development).  For U.S. affiliates, the data 
link will provide state-level detail on the U.S. location of the affiliates’ R&D activity. 
 
                                                 
10 A report examining the feasibility of this data link project is available on BEA’s 
Website at <www.bea.gov/international/pdf/FinalReportpublic.pdf>. 
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II.  Major conceptual questions 
This section addresses a selection of conceptual issues of particular relevance in 
attempting to develop the most informative and accurate measure(s) of R&D capital stock 
for BEA’s international R&D data.  The first issue—who benefits from the knowledge 
generated by R&D?—is closely linked to the ownership of R&D-generated knowledge 
assets.  In the national accounts, the owner of an asset is presumed to be its beneficiary, 
both because of an ability to use the asset in production and because of an ability to 
transfer ownership of the asset to another party.  However, with knowledge, the link 
between owner and beneficiary is less clear-cut than with more tangible assets.  The 
question of who benefits from R&D presents two conceptual problems from the 
perspective of economic accounting: spillovers and joint ownership.  It also presents the 
somewhat more practical issue deciding whether to assign R&D ownership to the R&D 
funder or performer.  The next three issues discussed are adjustment to R&D capital 
stocks for firm entry and exit, depreciation of R&D capital stocks, and construction of 
real estimates of R&D capital.  For each of these, data beyond those currently collected 
by BEA would be very useful.  The final two issues deal with consistency in translating 
the R&D data collected by BEA into estimates consistent with the R&D investment 
underlying R&D capital accumulation.  Many of the issues discussed in this section are 
exceedingly challenging to address satisfactorily; even a full-fledged effort to treat R&D 
as investment in international data might have to skirt some of them.  Although the list of 
issues considered in this section is not exhaustive, it serves to give a sense of the 
possibilities and limitations connected with a full-scale effort to treat international R&D 
as investment. 
A)  Knowledge beneficiaries 
The issue of who benefits from the knowledge capital created by R&D is 
problematic for efforts to treat R&D as investment in the same way as is done for the 
creation of physical capital.  Like many other intangible assets, R&D-generated 
knowledge can be at least partly non-appropriable—that is, there often are some benefits 
that the owner cannot prevent others from enjoying—and at least partly non-rival in 
consumption—that is, one economic agent’s use of the knowledge does not reduce the 
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amount of knowledge that is potentially available to another economic agent.  These two 
characteristics make clear identification of the knowledge beneficiaries difficult.
11  They 
lead to separate difficulties in economic accounting, which is usually premised on the 
ability to make clear distinctions between assets and to clearly identify asset owners.  To 
the extent that R&D-generated knowledge is non-appropriable, its creator (or subsequent 
owner) cannot extract some portion of the value of the knowledge from its ultimate users.  
As a result, the value to the owner of the R&D capital is less than its full value to society, 
so that the market transactions, which underlie the usual economic accounting methods, 
will understate the importance of R&D capital.
12  Put another way, non-appropriability 
results in spillovers of knowledge to others beside the legal owner(s) of the knowledge. 
i) Spillovers.  International knowledge spillovers have effects on economic 
accounting in the international context that are of the same nature as those that arise in a 
purely domestic context.
13  Specifically, the location of measured, private R&D 
investment capital stocks may be only tenuously connected to the location(s) of the actual 
beneficiaries of those stocks.  Measures of R&D investment flows and the resulting 
capital stocks may give a misleading indication of the availability and distribution of 
                                                 
11 Economic institutions and policies may mitigate the extent of non-
appropriability, often purposely so.  For instance, patenting is one method of limiting the 
unauthorized use of R&D generated knowledge.  In addition, a firm often goes to great 
lengths to keep secret its unpatentable (or unpatented) knowledge.  Modifying the size or 
scope of its activity is one way a firm might try to appropriate a greater share of the 
knowledge gleaned from R&D.  For instance, the firm may become more vertically 
integrated to keep for itself knowledge that would otherwise become available to 
upstream or downstream firms.  Another strategy might involve two competing firms that 
cannot keep their R&D knowledge from becoming known by each other merging to form 
a single larger firm.  Finally the multinational firm itself may sometimes serve as a device 
for maintaining control of knowledge capital while gaining the benefits from its use 
around the world. 
12 Another economic outcome that often results from non-appropriability is that, if 
unsubsidized, the activity in question occurs less than is socially optimal.  However, the 
fact that an activity might occur at a less-than-socially-optimal level does not, of itself, 
pose difficulty for the sort of economic accounting reflected in BEA’s accounts. 
13 Domestically, in the 2006 R&DSA report, the issue of spillovers was deferred, 
other than noting its complexity and that fully accounting for spillovers would to move 
beyond the national accounts convention of measuring private, not public (social) values.  
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usable R&D capital in economic production, both domestically and internationally.  
Growth actually resulting from application of R&D-generated knowledge may be 
misattributed or unattributed. 
From the U.S. perspective, even if its international accounts were adjusted to 
reflect the treatment of R&D as investment, they would not capture knowledge that spills 
over to other countries without explicit payment.  Similarly, they would not capture 
knowledge that comes from other countries free of charge.  Empirical estimates exist as 
to the size of certain types of R&D spillovers, but these are subject to a good deal of 
uncertainty and require numerous assumptions.  In particular, empirical investigations 
typically focus on a specific mechanism through which spillovers might occur or on a 
specific domain in which they might operate.  Further complications are that knowledge 
may spill over national borders at different rates than is the case within a given country; it 
may also spill over at different rates across different countries, or across different types of 
firms or industries.
14 
In this light, work on the international aspects of treating R&D as investment will 
follow the same route as taken for the main R&DSA.  The likely existence of knowledge 
spillovers is acknowledged, but no attempt is made at this time to estimate them or 
correct the resulting distortions. 
ii) Joint ownership.  The second characteristic of knowledge—non-rivalry in 
use—is equally vexing.  To the extent that R&D-generated knowledge is non-rival, one 
person’s use of the knowledge does not diminish the ability of others also to use it.
15  
(This is not to say that others’ use of knowledge might not have consequences in the 
marketplace; for example, one firm could face lower demand for its product if a second, 
competing firm were to use knowledge belonging to the first.)  One particular implication 
of non-rivalry is joint ownership.  For instance, two or more non-affiliated firms may 
                                                 
14 Although a review of the literature on spillovers is beyond the scope of this 
paper, the references at the end of the paper list several representative studies on R&D 
spillovers generally, international spillovers, and spillovers related to direct investment. 
15 A related characteristic of knowledge capital is that it does not “depreciate” due 
to use; it only depreciates in the sense that it diminishes in value through obsolescence. 
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collaborate on, and jointly own the results of, a given R&D project—a case exemplified 
by joint ventures among automobile manufacturers to develop and share common vehicle 
platforms or hybrid propulsion systems.  Or, one firm may perform R&D, and transfer 
rights for use of the resulting knowledge to another non-competing firm without giving 
up its own usage rights.  Perhaps most importantly for the present discussion, one entity 
(i.e., a parent or an affiliate) belonging to an MNC might perform R&D for use by other 
entities belonging to the same MNC, or for both itself and other MNC entities.
16  In all of 
these cases, a given firm will have the same degree of access to the knowledge derived 
from R&D as it would had it been the sole performer/owner/user of the R&D. 
From the point of view of economic accounting, the simplest situation with 
respect to R&D by MNCs would be if each part of the company (parents and affiliates) 
performed R&D for its, and only its, needs.  In practice, this not always the case.  MNCs 
tend to centralize their R&D more than their production for reasons such as avoidance of 
R&D duplication (an avoidance made possible by non-rivalry in use), scale economies in 
research, or a desire to keep the generated knowledge secret.  All else equal, R&D might 
naturally concentrate near company headquarters, but several other considerations (e.g., 
tax policy, labor or other input costs, opportunities to receive spillovers, research 
proficiency of the available labor force, and opportunities for collaboration with 
universities) affect R&D location decisions.
17 
A simple example illustrates the conceptual problem of accounting for non-rival 
R&D.  Suppose that a U.S. company conducts research for itself that costs $3 million, 
generating process X—specific knowledge that it uses in production.  Under the current 
methodology (and abstracting from depreciation), the research increases the U.S. R&D 
capital stock by $3 million.  Later, the company acquires an affiliate in Country A, a 
market in which the company previously had not participated.  As part of the acquisition, 
                                                 
16 This case touches on both non-rivalry and non-appropriability—non-rivalry for 
reasons to be discussed in the paragraph that follows, non-appropriability in that the 
MNC itself may owe its existence, at least in part, to a desire to internalize what would 
otherwise become knowledge spillovers, as noted in footnote 11. 
17 See, for example, Feinberg and Gupta (2004) and Thursby and Thursby (2006a) 
and (2006b). 
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the new U.S. parent provides the affiliate—either with or without charge—the knowledge 
that is process X.  However, due to non-rivalry, the U.S. parent retains the rights to use 
process X in its own production, just as it did before becoming a parent. 
The problem is that it isn’t clear conceptually what this new affiliation should 
mean for the size of R&D stocks in the United States and Country A.  From one 
perspective, the U.S. R&D capital stock ought to remain the same, as the U.S. company 
has the same ability to use process X as before it took on the new affiliate.  From another 
perspective, the R&D stock in country A should rise, as it now has access to process X.  
However, these two perspectives together imply an increase in the worldwide stock of 
R&D (and in the MNC’s R&D stock) without any actual performance of R&D.  
Expressed differently, the problem is that the domain of measurement—the country—
does not encompass the unit across which ownership of the R&D is shared—the MNC.   
Moreover, the non-rivalry in use means that the asset at issue can not be cleanly allocated 
in a way that the country parts sum to the world total.
18 
                                                 
18 One potential conceptual solution for this problem would be to assume that the 
value of the knowledge generated by R&D reflects all potential knowledge-sharing 
scenarios.  In the example just presented, this would presume that the value of R&D is 
initially recorded such that it takes into account both its own use of process X along with 
the value of process X to the potential affiliate (and, for that matter, its value to any other 
company the R&D performer might wish to include as a shared owner or licensor).  In 
fact, it might be reasonable to expect that the performer bears the $3 million costs of 
R&D taking into account all of these potential benefits, so that cost-based R&D data 
would largely reflect such value.  Completing the example, when the performer shares 
the knowledge with its affiliate, part of the $3 million value of the knowledge is 
transferred away from the performer to the affiliate, even though the benefits which 
process X bestows on its own (the performer’s) production is unaffected.  The U.S. R&D 
capital stock falls and that of country A rises. 
The “solution” just described is not fully satisfactory because it leads to a 
“sources of growth” problem.  Suppose that U.S. GDP was unchanged from before the 
sharing of process X with the foreign affiliate to after its sharing.  Suppose further that 
the only change to the U.S. capital stock was the decrease associated with the sharing of 
process X.  Then there would be a decrease in the apparent use in the factors of 
production without a concurrent decrease in production itself.  By default, measured 
productivity would rise, despite no actual change in productivity. 
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An important reason to measure capital holdings is to measure productivity and 
the sources of output growth.  This goal would suggest that R&D stocks should be 
allocated to all locations where they are used for production.  Allowing the affiliate in 
Country A to use non-rival R&D assets developed by its U.S. parent increases its 
productive capability (and by extension that of the host country) without diminishing the 
productive capability of the parent (and its country).
19  Therefore, from a theoretical 
standpoint, it could be argued that the affiliate’s access to process X should be recorded 
as both an increase in its R&D capital stock and an increase in the MNC’s and worldwide 
capital stock, on the grounds that the increase in stock represents a real increase in 
production possibilities and is not just an accounting anomaly.
20 
The unattractive aspect of this treatment is that R&D capital stock may vary 
independent of the level of current R&D activity.  However, a number of forces tend to 
limit the likelihood of a significant quantitative disparity.  As noted above, an MNC 
would be expected to choose its spending on R&D taking into account the fact the results 
may be shared.  If this happened, the R&D cost would reflect the sharing arrangements.  
Further, the relatively high depreciation rate on R&D stocks should limit the quantitative 
effect of acquisitions unanticipated at the time of the original investment.  When the 
stocks depreciate quickly, the current stock mostly reflects investment done recently. 
Joint ownership also creates some practical difficulties for the measurement of 
R&D capital stocks using recorded payments and receipts.  Two are notable:  flows of 
knowledge that are ambiguously priced (perhaps for strategic reasons), and flows that 
occur without payment.  For the issue of ambiguous pricing, consider another example:  
Two affiliated firms within an MNC face a common technological challenge and jointly 
finance a research venture.  How much of the ownership of the R&D should be allocated 
to each?  Both will have full access to the resulting knowledge, but one may benefit more 
than the other (for a variety of possible reasons), so splitting the ownership in half is not 
                                                 
19 See McGrattan and Prescott (2007) for a theoretical illustration. 
20 This effect is not just an international issue.  If a U.S. MNC acquires an 
additional establishment within the United States and allows it to use the parent’s R&D, 
U.S. productive capability increases.  The capital and labor in the new establishment is 
more productive with the parent’s R&D than without it, just like in the international case. 
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the obvious solution.  From the perspective of the unified MNC, however, tax or other 
considerations may make it advantageous to skew the costs towards one firm.  Economic 
accounts that measure R&D ownership by funding can mislead for this reason.  This is 
conceptually similar to transfer pricing problems with sales of tangible goods between 
related parties, but the scope for cost shifting is likely greater here due the nature of joint 
ownership and the greater uncertainties surrounding the values of intangible assets. 
That at least some portion of R&D is shared without any payment at all to the 
R&D performer is another possibility.  For instance, a U.S. parent might fund and 
perform all of an MNCs’ research.  While it may receive royalty payments for some of 
the more easily defined knowledge outputs, some of the resulting knowledge might be 
more amorphous, or tacit, and shared with its affiliates without charge.  To the extent this 
occurs, the R&D capital stock of affiliates would be understated.
21 
iii) Funder versus performer.  Aside from spillovers and joint ownership, one 
other aspect of the question of who benefits from R&D requires mention.  Even if it is 
assumed that R&D can be cleanly measured and allocated, to which of the various parties 
associated with R&D or R&D-related transactions should R&D be connected?  As 
observed by Moris, R&D might be connected to the R&D performer, its funder, or its 
user, with each different connection serving a different accounting perspective.
22  From 
the perspective of the relationship of R&D capital to production, it seems most 
reasonable to connect R&D with its user, that is, to assume that the benefits of R&D 
accrue to its user (whether the user is the performer, the funder, or neither).  Survey data, 
however, usually do not identify the users of R&D capital.  The MNC operations data, in 
particular, focus on R&D expenditures, documenting either R&D funding or R&D 
performance activity.   
                                                 
21 The provision without charge of intellectual property (or other failures of U.S. 
economic accounts to capture flows of intellectual property) is at the heart of the “dark 
matter” explanation of persistence in international investment position imbalances.  
However, the dark matter idea does not require that assets be jointly owned.  For more on 
dark matter, see Hausmann and Sturzenegger (2006) and Kozlow (2006). 
22 Moris (2007), (p. 13). 
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The expenditures data collected in the MNC operations surveys underlie the entire 
calculation of R&D capital in the perpetual inventory method.  From those expenditures 
data, R&D investment is calculated, allowing, in turn, for the calculation of R&D capital 
stocks and depreciation.  The calculation of R&D investment must be based either on 
performance expenditures or funding expenditures.  In the R&DSA, investment is 
estimated on funder basis, as it is the funder that is normally the legal owner of the 
R&D.
23  With respect to MNCs’ R&D, the issues are quite similar to those that arise for 
domestic investment in the R&DSA.  Operations data are available on either R&D 
funding or R&D performance (though, often only one of the two).  When possible, R&D 
capital estimates for MNCs should be based on funding, rather than performing, 
expenditure data.
24 
B)  Entry and exit 
An issue particularly relevant to estimates based on the MNC operations data is 
firm entry and exit from the MNC universe (population).
25  Specifically, whenever a firm 
becomes part of an MNC—by acquiring/establishing an affiliate overseas or by being 
acquired/established by a parent in another country—the MNC R&D capital stock rises, 
apart from any R&D investment that might occur.  Similarly, exit from the universe 
results in a drop in the capital stock unrelated to current depreciation.  The issue is 
actually somewhat broader:  acquisitions of same-country firms by entities belonging to 
MNCs (or divestitures to same-country buyers of parts of such entities) also change the 
stock of R&D capital without investment (or depreciation) per se.  Surveys on the 
operations of MNCs’ do not collect data on such changes in the R&D capital stock, so 
any estimate of changes in this stock based solely on investment and depreciation will be 
biased downward (assuming that entries generally exceed exits). 
                                                 
23 Okubo et. al. (2006), p. 15. 
24 The order-of-magnitude estimates presented later base R&D investment 
estimates on funding data when possible.  However, for several years, only performing 
data are available.  In such years, R&D funding is estimated from the performing data. 
25 The definition of direct investment used for BEA’s surveys of MNCs (including 
operations surveys) requires a parent ownership share of affiliates outside the country of 
the parent of 10 percent or higher. 
  19   October  2007 
 
Data that might help to estimate the effects on R&D capital of entry (as broadly 
construed to include the effects of entry, exit, and same-country acquisitions and 
divestitures) are available to varying degrees from surveys on the operations of MNCs.  
Information on instances of entity entry and exit is collected on MNC surveys, but it can 
be somewhat noisy as some cases of apparent entry/exit are actually due to reorganization 
or to changes within the MNC universe in the ownership of existing entities.  Part, but not 
all, of this noise can be removed with some effort.  Information on entry and exit might 
be combined with data on variables correlated to R&D stocks (such as physical capital 
stocks or R&D investment flows).
26  In addition, surveys of new investment in the United 
States include total assets data for entering U.S. affiliates and acquisitions of existing 
affiliates.
27  However, information on same-country acquisitions or divestitures is not 
generally available for U.S. parents or for their foreign affiliates. 
Alternatively, data are available on the size of physical capital investment and 
depreciation flows relative to overall changes in physical capital, permitting the 
calculation of the entry effects on physical capital stock as a residual.  To the extent that 
the relative sizes of R&D-capital entry effects are assumed to be similar to those of 
physical capital, the latter may provide the basis for producing estimates of the R&D 
entry effects.
28  However, the residual is quite noisy; differences in the type of stock 
measure used for physical capital, and the possibility of other reasons for changes in the 
physical capital stock make for a rather crude adjustment even at the aggregate level.  At 
more detailed levels, such an approach may not be fruitful. 
                                                 
26 But note that the correlation of industry-level physical capital with industry 
level R&D is not particularly high.  Within industries (or, at least, certain industries) the 
correlation might be higher. 
27 These data are not netted against exits and divestitures, so are somewhat limited 
in their utility. 
28 The order-of-magnitude estimates presented later in this paper incorporate this 
methodology. 
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C)  Depreciation 
A good deal of attention in work on the R&DSA has been, and continues be, paid 
to the issue of the appropriate rate and methods to use in depreciating R&D capital.  As 
observed in the 2006 report, R&D capital depreciation results from obsolescence or 
leakage, not actual deterioration or loss of knowledge.
29  R&D depreciation rates 
generally are not objects of direct observation.  Some researchers have attempted to 
estimate depreciation rates, but the ranges of estimated depreciation rates are large and 
the correct pattern of depreciation is uncertain.
30  In principle, both rate and pattern may 
vary widely across industries and types of R&D. 
Despite the uncertainty, depreciation methods and rates applied in the R&DSA to 
the R&D capital stock of U.S. private industry are likely to be appropriate for the stocks 
of U.S. parents and U.S. affiliates, given their high share of U.S. R&D funded and 
performed.  For foreign affiliates, the issue is less clear, for at least two reasons.  First is 
the that the nature of R&D as performed and used outside of the United States by foreign 
affiliates may differ from that in the United States.
31  Particularly in less technologically 
advanced areas, R&D may be heavily weighted towards development and away from 
basic research.  Affiliates may gear their own R&D towards adapting parents’ existing 
products and processes to local conditions rather than toward creating something more 
unique.
32  Also particularly in less advanced areas—though this may be less of an issue 
                                                 
29 Leakage (from the R&D owner to its competitors) is surely a source of 
depreciation from a private perspective, but is much less surely one from the perspective 
of the economy as a whole. 
30 The 2007 R&DSA report considers research on R&D depreciation rates at 
greater length. 
31 The number of studies on R&D depreciation rates in foreign countries is limited 
compared to studies on depreciation rates in the United States.  However, see 
Schankerman and Pakes (1986) for a study focusing on patent rights in Europe.  
Estimated depreciation rates in that study vary widely over time and country. Given the 
wide range of rates in U.S. and foreign studies, it would be difficult to determine whether 
foreign rates differed fundamentally from U.S. rates, even if a greater number of studies 
were available on foreign depreciation rates. 
32 Feinberg and Majumdar (2001) find evidence of this in the Indian 
pharmaceutical industry. 
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for foreign affiliates than for indigenously owned firms—R&D might be geared to 
“imitation” as opposed to “innovation,” activities that might have different life-cycle 
expectations. 
Another reason that U.S. R&D depreciation rates may differ from those of foreign 
affiliates is differences in the legal, regulatory, and competitive environments.  If 
intellectual property protection is weaker or more narrow in one country than another, or 
if a patent expires more quickly in one country than another, R&D capital might be 
expected to obsolesce or leak at a more rapid rate in the former country.
33  A similar 
result might occur if labor market institutions permit employees involved in the 
performance of R&D in one country to leave a firm and find a job at another, or to found 
a new firm, more easily than in another country.  The quality and size of the pool of 
potential researchers in one country relative to that in another might also affect the rate at 
which a given research investment depreciates.  In particular, if a country’s researchers 
are relatively weak in a given technological area and therefore slow to generate 
knowledge that renders earlier ideas obsolete, any research result that is obtained in that 
area might depreciate relatively slowly,  
This paper does not aim to provide answers to the question of how foreign 
affiliate depreciation rates actually do differ from U.S. rates, leaving that to a future stage 
in the project.  In that prospective stage, the most expedient approach will likely start 
with industry-level rates used in the R&DSA and supplement them with evidence (or 
plausible arguments) for incremental differences. 
D)  Construction of constant-dollar estimates 
Another matter of significant ongoing import in the R&DSA work is that of 
finding an appropriate method to deflate R&D investment in creating real (that is, 
                                                 
33 This presumes that the worldwide economy is less than fully open or fully 
integrated in some manner.  If firms compete without frictions against all global 
competitors, a U.S. firm would be just as worried about British or Chinese R&D 
rendering its knowledge obsolete as about U.S. R&D (or as worried about knowledge 
leakage to competitors in those countries as to U.S. competitors).  It is probably safe to 
assume that, at least for some industries, such a frictionless marketplace does not hold. 
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constant-dollar) measures from current-dollar data.  To be fully satisfactory, the deflation 
method must be capable of revealing productivity growth in the performance of R&D.  
The fundamental problem is the lack of R&D prices indexes, a situation due both to the 
difficulty in measuring a “unit” of R&D and to the fact that only a small share of R&D 
performed is sold on the open market.  The 2007 R&DSA uses two separate types of 
prices indexes to deflate prices of domestic R&D—one is based on input costs and the 
other on output prices in R&D-investing industries—but neither directly measures prices 
of R&D output itself. 
Work on this stage of the international R&D capitalization project will bypass the 
issue of R&D price deflation.  Deflation is required to convert current-cost capital stock 
estimates in one year to current-cost estimates in the next, but not to develop current-
dollar investment estimates.  These current-dollar estimates will be the only investment 
estimates addressed at this stage.  Later-stage work—if it generates constant-dollar 
estimates—will draw on methods developed for the R&DSA, along with data—to the 
extent available—on relevant foreign prices.  Because such work is potentially quite 
extensive given the number of countries involved and the variety in the data definitions 
and detail over countries, the expected benefits of the work should be assessed relative to 
available resources.
34  For the R&D of foreign affiliates in host countries without detailed 
price data, data could be deflated by broad purchasing power parity price indexes. 
E)  Treating R&D as investment, consistency adjustments 
The estimates of R&D investment that feed into estimates of R&D capital are 
primarily based on survey data of R&D expenditures.  However, R&D expenditures data 
collected on surveys are not necessarily entirely consistent with the relevant economic 
accounting definitions for R&D investment.  To convert expenditures data to investment 
estimates, certain adjustments are necessary (or at least desirable).  This section identifies 
several possible adjustments that might be made to R&D expenditures so that they more 
accurately reflect R&D investment.  However, note the following caveats:  1) it may not 
                                                 
34 At least initially, this work could be modeled after procedures currently used by 
BEA’s balance of payments division to deflate capital stocks of U.S. and foreign 
affiliates in constructing current-cost measures of the international investment position. 
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be possible to make some of these adjustments given available data; 2) even if it were 
possible to make all of them, their effect would likely be relatively small. 
For the R&DSA, international R&D data supplement the primary data on 
domestic R&D expenditures from NSF; imports of R&D are added into domestic 
investment and R&D exports are subtracted.  Given the current classification system 
described in the previous section, the imports included in domestic R&D investment 
would consist of the R&D portion of R&D and testing service payments, and that part of 
payments for rights related to industrial processes and products involving a transfer of 
ownership (and, possibly, long-term leases with similar characteristics).  Similar 
distinctions apply to exports.  Neither of these parts are extractable from the larger 
categories to which they belong.  Testing services are thought to be a minor component 
of R&D and testing services.  Much of the value of payments for rights related to 
industrial products and processes may be for the short-term rental of R&D output; such 
transactions should not be considered to be transfers of capital.  However, the exact 
magnitude of this material exclusion is unknown.  The 2007 R&DSA report uses data on 
trade in R&D and testing services, but it will not use data on trade in rights related to 
industrial products and processes. 
For the MNC operations data, several adjustments might, in principle, be made to 
make them more comparable to NIPA estimates and with R&D investment as defined 
(though not necessarily currently implemented) for the R&DSA.  First, the R&D 
expenditures data are collected on a fiscal-year basis in the operations surveys.  For 
consistency with the ITAs and NIPAS, these should be converted to a calendar-year 
basis.  The adjustment would likely be relatively small as well over half of operations 
data are from firms whose fiscal year coincides with the calendar year.  Operations 
surveys do request information on the ending date of the fiscal year used on each report, 
but the adjustment made possible by this information would be somewhat rough. 
Second, the R&D (funding) expenditure data do not completely adjust for post-
funding purchases and sales (or leases) of R&D output.
35  Such an adjustment would be 
                                                 
35 The post-funding transactions should be accounted for in the MNC R&D 
expenditure estimates for the same reason that domestic R&D investment data should be 
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very difficult to make in practice.  Although the funding data collected on BEA’s surveys 
of MNC operations do appropriately include data on R&D performed by others on the 
MNC’s behalf, they do not include purchases of already-completed R&D.  Similarly, 
they do not exclude own-account R&D that is later sold to an outside party.  While a 
portion of post-funding transactions are reportable on surveys of international trade in 
services, transactions that involve a domestic (or, for foreign affiliates, host country) 
partner are not.  For foreign affiliates, transactions involving a third-country partner are 
also not covered. 
A third adjustment that would move the operations data in the direction of 
consistency with the R&DSA is to remove current-year expenditures on computer 
software that currently are included in own-account R&D data and add back in the 
current-year depreciation of the stock of computer software (in essence, treating software 
as a capital good rather as a current expense). 
Fourth, and related to the third adjustment, the depreciation of physical capital 
that is implicitly included in own-account R&D expenditures could be adjusted to reflect 
actual economic depreciation of current-cost capital stocks, rather than financial 
depreciation of historical-cost capital stocks.  Although MNC data do not exist to make 
this or the third adjustment, if work on the domestic R&DSA shows that these 
adjustments are quantitatively important, scaling factors might be inferred and borrowed 
from their work. 
Fifth, existing R&D capital might be used in the generation of new R&D capital.  
To the extent that it is, R&D capital depreciation should be added into the R&D 
investment measure, following the treatment used for computer software and physical 
capital.  Again, data upon that could be used to calculate such an adjustment are not 
available. 
                                                                                                                                                 
adjusted for imports and exports of R&D.  That is, these post-funding transactions are 
another channel—besides the funding of new R&D or the depreciation of existing 
R&D—through which the stock of R&D capital changes 
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Finally, survey data should be adjusted to include R&D in the social sciences and 
humanities and to exclude expenditures for commercialization.
36  This last adjustment 
would bring R&D estimates into line with Frascati Manual definitions of R&D.  Data are 
not collected in surveys of MNC operations that would allow for calculation of this final 
adjustment.  If this adjustment, or any of the other adjustments previously mentioned for 
which MNC data are lacking, were to be made, they would have to be based on outside 
data.  Where possible, and where such adjustments are made in the R&DSA, they would 
likely follow those adjustments to the R&DSA estimates. 
As just discussed, several adjustments could, if the needed data were available or 
could be reliably estimated, be made to bring data on MNCs’ R&D expenditures into 
closer agreement with the appropriate notion of investment in R&D.  Whether the 
resulting benefits would merit the resources needed to do so is a separate question, 
particularly if changes to surveys are contemplated.  Worth considering in this regard is 
how much or how little attention is given to similar issues concerning MNC physical 
capital data.  While the details of BEA’s treatment of international data on physical 
capital are beyond the scope of this paper, in general the approach is to collect physical 
capital data on the basis most readily provided by MNCs (e.g., fiscal-year data, historical-
cost stocks with depreciation based on financial accounting rules).  To date, adjustments 
generally have been made only in applications connected to ITA or IIP estimates, and 
only at the aggregate level or other relatively high levels of aggregation. 
F)  R&D trade data consistency 
The current classification scheme used by BEA differs somewhat from the 
international standards recommended by the International Monetary Fund in the current 
Balance of Payments Manual (BPM5) and from the (different) scheme likely to be 
recommended in the next balance of payments manual (BPM6).  In BPM5, outright sales 
of R&D-generated intangible property (such as patents) are to be excluded from the 
current account altogether and, instead, recorded in the capital account.
37  Only 
                                                 
36 Okubo, et. al. (2006), p.16 (table A). 
37 International Monetary Fund (1993), paragraph 358 (p.84-85). 
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transactions related to the use of such intangible property, without outright transfer of 
ownership, are to be recorded as royalties and license fees.
38  The most recent draft of 
BPM6 recommends that outright sales of intangible assets resulting from R&D be 
recorded as R&D services trade.
39  Under this recommendation, the distinction between 
the transactions of R&D capital classified as R&D services trade and those classified as 
royalties and license fees (renamed “fees for franchises and other proprietary rights”) 
hinges on the ownership of the R&D results, rather than on the timing of the research 
relative to the transaction.  That is, regardless of whether the R&D results from a 
purchaser entering into a specific arrangement to have the R&D performed on its behalf, 
or from a purchaser identifying and choosing to buy an existing R&D result, the 
transaction will be classified as R&D services trade as long as the ownership to the R&D 
result is transferred.  To the extent that rentals or leases of rights to tangible assets do not 
increase the quantity of capital stock accounted as held by the renter/lessor, the new 
recommendation may lead to a cleaner measure of national holdings of R&D capital 
stocks, as all transactions in the R&D services trade can be included and all transactions 
in rights to intangible assets can be excluded for the purposes of computing the U.S. 
R&D capital stock. 
 
III.  Data issues 
This section moves away from conceptual issues to look at practical issues that 
must be confronted in constructing estimates of international R&D investment and capital 
stock values, as well as those of associated data items.  The order-of-magnitude estimates 
in the next section incorporate decisions regarding several such issues, ones that are 
affected by considerations of both estimate precision and application simplicity.  This 
section examines some of these issues—data series length, other related data, and level of 
                                                 
38 In practice, BEA occasionally records outright sales of R&D-generated 
intangible assets in the capital account, as recommended by BPM5—rather than in the 
royalties and license fees category of the current account, as is typical practice.  It does so 
primarily when the transactions are very large and can be definitively identified as sales. 
39 International Monetary Fund (2007), paragraphs 136 and 138 (p. 210-211). 
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aggregation of the estimates—at a higher level of generality than is done in that section.  
Compared to the order-of-magnitude estimates described there, the research plan is for 
estimates made in future stages of the project to treat international R&D as investment to 
place greater emphasis on data precision, at the expense of simplicity in application.  This 
section also considers possible changes to BEA surveys that would enhance the ability to 
generate accurate international R&D capitalization estimates. 
It is worth emphasizing that a number of the problems that the paper identifies are 
fundamental in the sense that they are not likely to be fully resolved simply by collecting 
more data.  Some are problems conventional to many surveys, such as differing 
definitions across surveys, and can be resolved or mitigated in future releases by 
changing surveys.  Others are more fundamental, stemming from an absence of market 
transactions or lack of an agreed accounting treatment.  A number of the issues discussed 
in Section II are data issues of this sort.
40  Therefore, unless the market changes and 
R&D assets become widely traded or accounting rules change to require full 
capitalization of R&D, solutions to these problems are unlikely to come from survey data
alone.  Instead, solutions will either require significant use of imputations and other non-
survey methods or will be limited by the market portion of the R&
 
D transactions. 
                                                
A)  Length of data series 
The estimates produced for the 2007 R&DSA apply to the years 1959 to 2004.  
International R&D data do not date back quite as far.  Data on international trade in R&D 
date back only to 1986 for unaffiliated transactions and only to 2001 for affiliated 
transactions.  Unaffiliated payments and receipts data on royalties and license fees for 
industrial processes date back to 1987.
41  For use in the domestic R&DSA, it is necessary 
to extend data series back to 1959 (or at least as far back as the magnitudes of the 
estimates remain material). 
 
40 For example, the entry and exit issues discussed arise not just because surveys 
do not ask for data on R&D stocks of acquired and divested firms.  The balance sheet of 
an acquired affiliate does not have an entry that corresponds to current value of all R&D 
assets, so it will be difficult to ask questions that would elicit useful information. 
41 As noted earlier, regular data collection on this type of royalty and license fees 
for affiliated transactions was only initiated in 2006. 
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Data on MNCs’ R&D expenditures extend back to different years for inward and 
outward investment.  Data for U.S. affiliates are available annually for 1977-2004, and 
(separately) for 1974.  Data for U.S. MNCs are available annually for 1989-2004, with 
single-year estimates also available for 1966, 1977, and 1982.  There are two basic 
questions:  can expenditure data for missing years be estimated with reasonable precision 
(and, if so, for how many missing years), and how many years of estimates of R&D 
capital will this support?  The order-of-magnitude estimates in the next section carry both 
of these series back to 1966; carrying the series back this far likely has little effect on 
estimates for the most recent years but may be misleading for the early-year estimates.  
Thus, for any publicly disseminated estimates, it may be prudent to begin the series 
somewhat later or to flag the estimates for early years as experimental and subject to 
error. 
B)  Related data 
Aside from the R&D capitalization estimates themselves and their effects on other 
key data items such as those discussed in section I and featured in the order-of-magnitude 
estimates, the capitalization estimates have potential implications for some other data 
items published by BEA.  In the MNC operations data, for instance, changing the 
treatment of R&D might oblige a change in published estimates of income statement 
items (e.g., total costs and expenses, costs of goods sold) and balance sheet items (e.g., 
total noncurrent assets, accumulated depreciation, retained earnings).  There are at least 
three options:  1) ignore the implications for these items, continuing to publish estimates 
on the present basis (that is, a financial accounting basis); 2) change the treatment of 
these items to fully reflect the change in the treatment of R&D; 3) publish data on both 
bases.  In the initial efforts to quantify the effects of treating R&D as investment, 
adoption of the first option would probably be the most prudent course.  If the treatment 
of R&D as investment later expands to more cover disaggregated estimates, the second 
option might be considered, but only if the R&D investment and capital stock estimates 
are put on a consistent basis with physical capital estimates; either the R&D estimates 
would need to remain on a financial accounting basis or the physical capital estimates 
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would need to be adjusted to an economic accounting basis.  Resource constraints  and 
disclosure concerns likely would make the third option infeasible. 
C)  Level of aggregation 
Surveys of international trade in services collect data by industry of the U.S. 
transactor, and by country of the participating foreign transactor.  Published estimates of 
this trade focus on the country dimension.  Estimates of R&D trade by U.S. industry are 
not published externally.
42  For purposes of extending the R&DSA in the industry 
dimension, estimates of trade by industry are needed.  Unpublished data collected on 
these surveys are available, but confidentiality restrictions may limit their usefulness by 
restricting the extent of industry disaggregation.  The 2007 R&DSA will make use of 
these unpublished data to generate estimates for a moderate number of industries. 
In the MNC operations surveys, data are collected by country of location of 
foreign affiliates, for outward investment, and by country of ultimate beneficial owner 
(UBO) for inward investment.
43  Information is also collected on the industries of U.S. 
parents, their foreign affiliates, and U.S. affiliates of foreign companies.  For the order-
of-magnitude estimates included in this paper, the estimates shown are all at the 
aggregate level, but future work might produce more disaggregated estimates.  However, 
substantial resources would likely be required to produce and suppress disaggregated 
estimates; this presents a major obstacle to their actual production.   
From a practical point of view, even if sufficient resources could be obtained, data 
suppression still would pose some difficulty.  The problem is that each year’s R&D 
capital stock estimate is built up as a (modified) sum of R&D investment data over prior 
years.  For any estimate that is formed as the sum of several other estimates, suppression 
of one any one component requires suppression of at least one other component, or of the 
                                                 
42 However, unpublished, industry-level data have been used in a limited number 
of research studies including Robbins (2006b) and Yuskavage, Strassner, and Medeiros 
(2006). 
43 For inward investment, information is also available on the country of the 
foreign parent (immediate owner), but data on U.S.-affiliate operations are usually 
presented by country of UBO. 
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sum itself, if the sum is not to reveal the originally suppressed component.  As a result, 
the suppression of a single year’s investment data generally would require suppression of 
capital stock data for the next several years.
44 
Another issue is that, compared to estimates of tangible capital investment and 
stocks in the NIPAs or that used to adjust the ITAs, estimates of R&D as investment are 
more likely to rely on assumptions that are the product of educated guesswork (as with 
the depreciation rates applied, for example).  These assumptions might be different for 
different countries as well as different industries and differences in assumptions could 
inadvertently drive differences in results for the various data subcategories.
45 
Aside from the question of the level of aggregation at which estimates are 
published is the question of the level of aggregation at which data are kept in BEA’s 
internal databases.  In principle, estimates of R&D investment and R&D capital stocks 
could be carried down to the level of the individual affiliate or parent in the same way 
that value added estimates are currently constructed.
46  One particular advantage to such 
an approach would be relative simplicity in dealing with industry changes of MNCs, 
whether due to changes in the activities of the MNCs or due to industry redefinitions 
(e.g., the switch from SIC to NAICS).  A disadvantage is that the existence of firm-level 
(internal) “estimates” that are not directly tied to reported data could lead to a false sense 
                                                 
44 For data going forward, this might be less of a problem as one year’s 
investment data can intentionally be suppressed to cover the previous year’s suppression, 
without leading to several years of suppression of capital stocks.  For data going back, the 
investment data have already been published, and thus cannot be arranged to minimize 
suppression in the stock series. 
45 As a concrete example, suppose that R&D held by foreign affiliates in less 
developed countries is, due to relatively weak protection of intellectual property, assumed 
to depreciate more quickly than R&D held by affiliates in developed countries, and this 
assumption is built into the estimation process.  This built-in assumption may itself be a 
primary driver of differences in the measured rates of growth of R&D capital stocks in 
the two areas. 
46 This does not mean that value added estimates at the affiliate or parent level are 
publicly available; it simply means that the published estimates at any level of 
aggregation are constructed by summing the value added estimates for each individual 
affiliate or parent in the relevant population. 
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of precision that would not arise if the only estimates were of higher-level aggregates 
(and could result in estimates with too much detail being published). 
D.  Data needs (potential survey changes) 
This section discusses potential changes to BEA surveys that might improve the 
accuracy of international estimates that treat R&D as investment.  Two possible changes 
stand out.  In the surveys of trade of international services and intangible assets, 
collecting data on sales separately from data on rentals (or other such limited 
arrangements) of R&D intangible property, rather than together as is current practice, 
would help clarify the actual transfer of R&D capital across borders.  This change would 
require that BEA determine how it wants to distinguish sales from rentals, that this 
distinction be clear to survey respondents, and that respondents be able to accurately 
provide the separate data.  Of these, respondent ability to provide the data might be most 
problematic.  The second change applies to MNC operations surveys.  On those, 
collecting data on R&D funding annually rather than just in benchmark surveys, in place 
of (or in addition to) R&D performance would provide for greater accuracy in estimating 
R&D investment, an improvement that would be particularly useful in the context of 
disaggregated estimates.
47 
Other possible changes would lead to data requests that would either be more 
difficult for reporters to provide or would provide smaller incremental benefits in 
estimating R&D capital than the two changes just identified.  In the surveys of trade in 
services, testing might be broken out of the research, development, and testing category.  
Financial and operating surveys of direct investment might (perhaps only in benchmark 
years) ask for a breakdown of R&D by type—basic research/applied 
                                                 
47 Data on R&D funding is, as already noted, collected in benchmark years.  The 
collection of R&D performance data has justifications of its own, unrelated to the 
treatment of R&D as investment, so collecting both types of expenditures might be the 
preferred alternative.  Among these justifications, performance data can shed light on the 
technological capabilities of the firms involved or on shifts in comparative advantage in 
R&D. 
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research/development or some similar taxonomy.
48  This would be of potential benefit in 
applying depreciation rates, as basic research, for example, is often viewed as 
depreciating more slowly than applied research or development. 
The operations surveys might also request data that would assist in understanding 
joint ownership of R&D by the various entities comprising MNCs.  For instance, where 
benchmark surveys currently ask for a breakdown of  
  (1) own-account performance/funding, 
  (2) performance for others, and 
  (3) funding of others.  
It might instead ask for a breakdown of  
  (1’) strictly-own account performance, 
  (2a’) performance jointly funded by self and others, 
  (2b’) performance strictly for others, 
  (3a’) joint funding of R&D performed by others, and 
  (3b’) individual funding of others.
49 
Finally, in order to obtain additional information on R&D costs, the operations 
surveys might collect data on compensation paid to R&D employees, to go along with the 
data collected on the number of such employees.
50 
 
                                                 
48 Recall that the project linking BEA’s MNC operations data with NSF’s U.S. 
private industry data will provide information on the type of R&D conducted by U.S. 
parents beginning with the  2004 data. 
49 “Others” here may itself be further broken down.  For example, the 2004 
benchmark survey of U.S. parents requested data on R&D performed for the parent itself, 
for its foreign affiliates, for the federal government, and for all others. 
50 The surveys of outward direct investment collect data on numbers of R&D 
employees only for benchmark years.  The surveys of inward direct investment collect 
such data annually. 
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IV.  Order-of-magnitude estimates  
This section presents order-of-magnitude estimates that illustrate the effect of 
treating R&D as investment in selected international data and that complement the central 
2007 R&DSA estimates.  It also presents and describes the simple methodology used to 
generate the estimates.  The effects of treating R&D as investment are carried through to 
several international-data annual time series estimates.  Data from surveys of the 
operations of multinational companies (MNCs) permit the estimation of R&D 
investment, capital stock, and depreciation from 1966 to 2004.  From these estimates, 
estimates are made of MNC value added for 1994-2004 and selected earlier years, of 
current-dollar direct investment income and related data for 1966-2004, and of the 
current-cost direct investment position for 1976-2004.  For the most recent year, 2004, 
the estimates increase direct investment income and the direct investment position by 
approximately 4-9 percent and generate increases in MNC value added in the same range.  
However, they have only small effects on balances and on higher-level ITA and IIP 
values.  The effects of the estimates are reasonably robust to differences in assumptions.  
The following shows the effects, measured in billions of current dollars, of treating R&D 
as investment on several key 2004 estimates. 














Foreign affiliates’ value added  824.3 850.2  25.9  3.1
U.S. parents’ value added  2,215.8 2,364.0  148.2  6.7
U.S. affiliates’ value added  511.5 539.6  28.1  5.5
Direct investment income (balance)  139.4 140.7  1.3  0.9
 (+) Outward  239.0 249.0  10.0  4.2
 (-) Inward  99.6 108.3  8.7  8.7
International investment income (balance)  56.4 57.7  1.3  2.3
 (+) Outward  401.9 411.9  10.0  2.5
 (-) Inward  345.6 336.9  8.7  -2.5
Current account (balance)  -640.1 -638.8  1.3  -0.2
 (+) Exports of goods and services and income receipts  1,559.2 1,569.2  10.0  0.6
 (-) Imports of goods and services and income payments  2,114.9 2,106.2  8.7  -0.4
 (+) Unilateral current transfers (net)  -84.4 -84.4  0.0  0.0
Rest of the world corporate profits (net)  176.3 177.6  1.3  0.7
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Direct investment position (net)  721.4 697.2  -24.2  -3.4
 (+) Outward  2,463.6 2,588.7  125.0  5.1
 (-) Inward  1,742.2 1,891.5  149.2  8.6
International investment position (net)  -2,294.4 -2,318.6  -24.2  1.1
 (+) Outward  9,257.1 9,382.1  125.0  1.4
 (-) Inward  11,551.5 11,700.7  149.2  1.3
 
In brief, the methodology uses perpetual inventory methods to create estimates of 
R&D capital stocks for U.S. parent companies, their foreign affiliates, and U.S. affiliates 
of foreign companies.  The treatment of R&D as investment does not affect the 
measurement of cross-border trade in goods and services, but it does affect U.S. receipts 
and payments of investment income in the current account of the ITAs and it affects the 
IIP.
51   Various measures of the operations of multinational companies also are affected.  
However, as those measures do not enter BEA’s national accounts, changes to those 
measures do not affect the domestic R&DSA data.  Estimates of some other international 
data that do affect national R&DSA estimates—specifically, estimates of R&D service 
imports and exports—are not presented here, as they have been separately incorporated 
into the domestic R&DSA. 
Data on U.S. receipts and payments of investment income come from BEA’s 
surveys of direct investment balance of payments transactions, where financial 
accounting rules are followed that generally treat R&D costs as current expenses.  
Furthermore, these surveys do not collect information on R&D that would permit BEA to 
generate alternative income estimates based on the assumption that R&D should be 
capitalized and the resulting stocks depreciated, rather than being expensed.  However, 
                                                 
51 Although treating R&D as investment does change the treatment of R&D 
stocks that have been obtained through international trade, it does not affect how the 
trade itself is recorded in the ITAs.  Therefore, as noted previously, treating R&D as 
investment has no effect on the balance on goods and services trade, as the flow of R&D 
service transactions continues to be recorded as previously.  However, its treatment as 
investment has an effect on the broader current-account balance through its impact on 
income payments and receipts. 
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separate, but related, BEA surveys on the operations of MNCs do collect R&D 
expenditure data.  From these data, estimates of R&D investment and capital stocks are 
generated, which, in turn, are used to adjust (for purposes of this exercise) existing 
estimates of the rest-of-the world component of corporate profits in the NIPAs, the direct 
investment income items in the ITAs, and the IIP.  In addition, these estimates of R&D 
investment and capital stocks permit the generation of modified MNC-value added 
estimates, which are broadly consistent with the current-dollar GDP estimates featured in 
the R&DSA. 
A key to the approach taken is to construct—separately for U.S. affiliates of 
foreign MNCs, U.S. parent companies, and foreign affiliates of U.S. MNCs—annual 
estimates of R&D capital stocks (and other associated data items) for MNCs.  As in the 
R&DSA, the perpetual inventory method is used to generate the stocks.  Under this 
method, an end-of-previous-year capital stock value is adjusted with current-year data on 
investment flows and depreciation to generate an end-of-current-year capital stock 
estimate.
52   Depreciation is estimated, also as in the R&DSA, under the assumption that 
the value of R&D capital decays geometrically.  Using a time series of investment data, a 
time series of capital stock estimates is constructed recursively. 
The estimation of MNC operations data proceeds in three main steps:  (1) 
conversion of R&D expenditures into R&D investment, (2) calculation of current-cost 
capital stocks (measured in current dollars), (3) and adjustment of value added estimates 
to account for treatment of R&D as a capital good.  For these initial estimates, no 
conversion of current-dollar values into real (constant-dollar) values has been 
attempted.
53   Below is a discussion of the methodologies involved with each of these 
                                                 
52 The term “amortization” is frequently used with intangible assets to denote a 
decay-in-value concept parallel to that of depreciation for tangible assets, one that, 
particularly for R&D, results primarily from obsolescence (rather than, for example, 
deterioration).  This paper instead follows the convention used in the R&D satellite 
project of applying the term “depreciation” to both tangible assets and R&D capital. 
53 The term “current-dollar” (or “in current dollars”) is used primarily in 
discussions of flow variables.  In contrast, the related term “current-cost” is used 
primarily in discussions of stock variables.  The flow variables derived here (e.g., R&D 
investment, value added, direct investment income) are presented in current dollars and, 
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three steps, as well as the methodology for using these operations-data estimates to adjust 
direct investment income receipts and payments, the rest-of-the-world component of 
corporate profits, and the IIP.  A summary of the estimates follows the discussion. 
A)  Conversion of MNC R&D expenditures into R&D investment 
The methods used elsewhere in the R&DSA to convert domestic R&D 
expenditures into R&D investment are taken as a model for this step.  In brief, domestic 
R&DSA uses data from NSF surveys and adjusts them in several ways for greater 
consistency with NIPA definitions.  The starting point of the order-of-magnitude 
estimates discussed here is data from BEA’s financial and operating surveys of U.S. 
MNCs and U.S. affiliates of foreign MNCs.  These data are collected on a basis 
consistent with that used in NSF’s Survey of Industrial Research and Development.  
Annual series of BEA survey data on MNCs’ R&D expenditures date back to 1989 for 
U.S. parent companies and foreign affiliates, and to 1977 for U.S. affiliates.
54   On 
benchmark surveys (currently conducted once every five years), data are collected on 
both R&D performance and R&D funding.  In annual surveys (conducted for non-
benchmark years), R&D data were collected on a funding basis until 1993 for outward 
direct investment data (i.e., for U.S. parents and foreign affiliates) and until 1996 for 
inward data (i.e., U.S. affiliates).  Subsequently, annual data have been collected on a 
performance basis. 
                                                                                                                                                 
in this sense, are consistent with existing (i.e., with R&D expensed) current-dollar 
estimates of these variables.  Of the stock variables derived here, the direct investment 
position and the IIP are measured on the same basis as their existing current-cost 
counterparts.  However, the stock variable, MNC’s R&D capital, is newly constructed 
here and has no currently published counterpart.  In addition, this capital stock measure is 
not directly comparable to BEA’s published estimates of MNC physical capital stock, as 
the latter measure is based on historical cost.  Additional discussion of the bases used in 
this exercise, and possible alternative bases, is scattered throughout this document where 
relevant. 
54 Data on MNCs’ R&D expenditures also exist for certain other (non-contiguous) 
years.  Data were collected for U.S. parent companies and foreign affiliates in benchmark 
surveys for 1982, 1977, and 1966.  For U.S. affiliates, R&D data were also collected in 
the benchmark survey for 1974. 
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Data on MNCs’ R&D expenditures are currently published at relatively detailed 
levels of industry (for U.S. parents) or country-by-industry (for foreign and U.S. 
affiliates) aggregation.  For these initial order-of-magnitude estimates, the estimates of 
R&D investment, R&D capital stocks, and value added are aggregate results, not 
disaggregated by country or industry.  However, if expansion and further development of 
this project occurs in the future, estimates of various industry and regional groupings, to 
complement those made at the aggregate level, may be feasible.
55 
This step consists of estimation of several years of missing data, along with 
making two minor data adjustments.  For estimating missing data, simple interpolation 
and extrapolation methods are used.  As these estimates are likely somewhat imprecise, 
estimates that depend heavily on early-year R&D expenditures—particularly 
expenditures before the mid-to-late 1970s—should be used with extra caution. 
Data adjustments include conversion of performance data to funding data for the 
most recent years and conversion of U.S.-affiliate data from an all-affiliate basis to a 
majority-owned-affiliate basis for early years (for consistency with the majority-owned 
foreign affiliate data).  For the conversion from a performance to a funding basis, funding 
data from benchmark survey data are used to interpolate funded-to-performed ratios for 
those non-benchmark years in which data were collected on a performance basis.  These 
ratios are then multiplied by values of R&D performed.  In general, this adjustment is 
relatively small.  (For the entities in question, most R&D is both performed and funded 
internally.)  For the conversion of U.S.-affiliate R&D data to a majority-owned basis, a 
ratio of 0.78 of all-affiliate data is used for years prior to 1992, a number broadly 
consistent with ratios for more recent years and ratios for other items. 
                                                 
55 Reasons for the focus on aggregates are both statistical and practical.  
Statistically, the relationship between R&D expenditures and the creation of 
commercially viable intellectual property is likely to be increasingly variable and 
uncertain the greater the level of disaggregation.  Practically, the amount of work 
required to provide estimates by industry or by country is beyond the scope of the current 
phase of this project.  In particular, issues of data suppression and changes in industry 
definitions (particularly from SIC to NAICS) would require substantial effort in terms of 
both planning and execution. 
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Aside from the performing-to-funding-basis adjustment, the R&DSA makes a 
number of other adjustments to the domestic expenditure data (e.g., removing 
expenditures on tangible capital and converting data from fiscal year to calendar year).
56   
No attempt has been made to perform similar adjustments for the MNC data at this stage; 
however, it is likely that the net effect of such adjustments would be small. 
B)  Calculation of current-cost R&D capital stocks 
i) Depreciation.  Three sorts of assumptions are required to transform R&D 
expenditures into R&D capital stocks.  First, assumptions are required as to the nature of 
R&D depreciation and the rate at which it occurs.  As mentioned above, it is assumed for 
these estimates that depreciation is geometric, with the R&D capital stock depreciating 
by a fixed percentage every year, regardless of the age profile of that stock.
57  For a first 
approximation, the rate used is that in scenario A of the 2006 R&DSA paper:  15 percent.  
As the proper depreciation rate is subject to some uncertainty (particularly in the context 
of R&D capital outside of the United States), two other depreciation rates—12 percent 
and 18 percent—are considered as alternatives to the 15 percent “base case” rate. 
One complication is that the 15 percent depreciation rate used for the 2006 
R&DSA paper is a real rate, not a nominal one.  To convert this real rate to one 
appropriate for nominal (current-cost) stocks requires that the “depreciation factor” 
(equal to one minus the depreciation rate) be multiplied by one plus the rate of price 
change.
58  For these estimates, the price change is assumed to be similar to the price 
                                                 
56 See Okubo, et. al (2006), p. 16 (Table A). 
57 In some other contexts, geometric depreciation rates are combined with service 
life estimates so that capital beyond a certain age is assumed to be fully depreciated.  
Without service life estimates, geometric depreciation rates imply that capital never fully 
depreciates, though its remaining value does eventually become vanishingly small.  For 
simplicity, these order-of-magnitude estimates will not use service life estimates.  
Consequently, there is no need to separately account for each vintage of R&D capital, a 
characteristic that is particularly advantageous in the context of firm entry and exit (an 
issue discussed later in this section). 
58 For instance, if the real depreciation rate is 15 percent and the price change is + 
5 percent, a capital investment of $100 in the current year will have a value of roughly 
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change in the broader economy, so the price change used is the change in the GDP 
implicit price deflator.  (Future work could incorporate a more narrowly targeted measure 
of price change.) 
ii) Starting year.  The need for the second assumption stems from a choice as to 
what year to begin the capital stock series.  One option is to begin the series as of the start 
of the first year for which investment data are available (1966).  This, however, requires 
an assumption as to the value of the initial-year capital stock.  The other option is to use 
the earliest years of investment data to build up capital stock values for a time series that 
would begin some years in the future.  The second option does not require an initial-year 
capital stock assumption, but at the cost of requiring a later starting date for the series.  In 
order to begin the R&D capital estimates in the earliest year possible—1966—the first 
option is chosen.  For this purpose, R&D capital stocks in 1966 are assumed to be 4 times 
the size of R&D investment in that year.  This factor of 4 times initial-year investment is, 
for example, approximately the factor that occurs when investment and the capital stock 
are growing at (common) steady-state rates of 8 percent and the depreciation rate is 15 
percent.
59  Two other alternatives are also considered:  capital stocks of 2.5 times, and 
capital stocks of 7 times, initial-year investment.  The former factor corresponds to higher 
depreciation and/or growth rates than is consistent with the base case assumption; the 
latter corresponds to lower rates. 
iii) Entry.  A third assumption is required because of an issue particularly 
prominent for MNCs:  firm entry and exit.  Specifically, the MNC R&D capital stock 
could rise in a given year – even were no R&D investment to occur in that year – simply 
by virtue of more firms being added to, or subsumed into, the MNC universe.  This 
would occur, for example, when a U.S. company with pre-existing R&D capital stock 
becomes a U.S. parent company as a result of a new direct investment abroad or when 
                                                                                                                                                 
$90 in next-year dollars (90 ≈ 100 x 0.85 x 1.05).  This translates into a nominal 
depreciation rate of roughly 10 percent. 
59 Other combinations of growth and depreciation rates also produce a factor of 4.  
The combinations yielding this outcome form a downward sloping line when plotted on a 
graph with the depreciation rate on one axis and the common steady-state growth rate of 
investment and capital stock on the other axis. 
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non-MNCs are acquired by (and subsumed into) existing MNC entities.  An adjustment is 
included each year to account for the change in the R&D capital stock resulting from the 
net existing R&D stock of entering and exiting firms (as opposed to the change in the 
stock resulting from R&D investment and depreciation).  The adjustment uses data on 
changes in the tangible capital stock to infer a (net) entry component for changes in the 
R&D capital stock. 
The adjustment relies on a two-part assumption.  First, the fraction of the increase 
in the tangible capital stock due to net entry (broadly construed, to include the above-
described types of entry and exit) is assumed to be a fixed value, EF (“entry factor”).
60  
Existing data provide some information as to the magnitude of this factor, but the 
information is not specific or comprehensive enough to compute the factor directly; 
analyst judgment is also required.
61  (Section A of the appendix provides a hypothetical 
example motivating the use and magnitude of the entry factor.)  For foreign affiliates, it is 
                                                 
60 Missing data for physical capital stocks are estimated with basic 
interpolation/extrapolation methods. 
61 Future work may entail estimation of entry factors that vary from year to year, 
to more closely approximate actual fluctuations in the relative importance of entry and 
investment, but such refinement is beyond the scope of this phase of the project.  For 
developing the fixed entry factor used here, data are available annually for U.S. affiliates 
and in benchmark surveys for foreign affiliates (but not at all for U.S. parents) that 
disaggregate the change in net physical capital stock into the portions due to 
expenditures, depreciation and depletion, sales and retirements (only for U.S. affiliates) 
of existing capital, and a residual category.  The assumed entry factor was informed by 
computed values of the ratio of the residual to the change in the physical capital stock.  
These ratios do not give particularly accurate measures of entry effects because (1) the 
residual includes effects other than entry and exit (in principle, it also includes the effects 
of revaluations of certain physical capital and, for foreign affiliate, sales and retirements 
of physical capital); (2) all data used for these calculations use historical cost stock 
measures; and (3) the ratios computed using these data are highly variable (including 
both values that are negative and values that are much greater than one). 
The magnitude of EF may appear larger than one would expect, since the share of 
operations, however measured, that is accounted for by firms that enter the universe in 
any given year will ordinarily be far smaller than its assumed values.  However, it should 
be recalled that a new entrant’s contribution to the increase in the R&D capital stock 
includes not only its R&D investment in that year (less depreciation), as is the case for 
existing MNC entities, but also capital accumulated in earlier years. 
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assumed that EF = 0.4  That is, if, hypothetically, the foreign affiliate tangible capital 
stock increases $100 million from one year to the next, then $40 million of the increase is 
presumed to be the stock held by entities that are new to the MNC universe, or the stock 
held by newly acquired parts of existing entities, both net of corresponding decreases 
(exits/divestitures).  The other $60 million is presumed to be due to investment during the 
year by existing entities, net of depreciation of existing entities’ stock.  For U.S. parents 
and U.S. affiliates, the entry factor is assumed to be smaller:  EF = 0.2 for U.S. parents, 
and EF = 0.3 for U.S. affiliates.
62 
The second part of the assumption is that the unknown R&D-capital entry 
component—scaled by the previous stock of R&D capital—is equal to the associated 
tangible-capital entry component—scaled by the previous stock of tangible capital.  In 
combination, these two parts imply that the entry component of R&D capital as a 
percentage of the (prior-year) R&D capital stock is an assumed fraction, EF, of the 
percentage change in physical capital, or  
     RDentry / RDstock(prior) = Kentry / Kstock(prior) = EF · %∆K 
where RD refers to R&D capital, K refers to physical capital, and %∆ denotes percentage 
change.  Equivalently, the R&D entry component itself is 
     RDentry = RDstock(prior) · EF · %∆K. 
                                                 
62 Higher entry factors were used for foreign affiliates and U.S. affiliates than for 
U.S. parents for two reasons.  First, growth rates of the populations of the foreign affiliate 
and U.S. affiliate populations have typically exceeded that of the U.S. parent population.  
It is reasonable to postulate that the differences owe more to higher rates of entry for 
foreign and U.S. affiliates than to higher rates of existing-firm growth.  Second, 
compared to U.S. companies and their potential entry into the MNC universe by 
acquisition of a foreign affiliate, potential foreign parents may be eager to acquire firms 
in a R&D-rich country such as the United States to offset the relative difficulty of 
generating R&D abroad. 
The reason higher entry factors were used for foreign affiliates than for U.S. 
affiliates is more subtle; the argument relies a higher rate of R&D investment for existing 
U.S. affiliates than for existing foreign affiliates.  Higher R&D investment, all else equal, 
lowers the entry factor by raising the denominator of the ratio that defines the factor (the 
denominator is the total change in capital).  Higher investment rates for existing U.S. 
affiliates would be expected if the United States had a comparative advantage in R&D, as 
seems likely.  Aside from this presumption, U.S. affiliate R&D performance is a higher 
as a ratio to (published) value added than the corresponding foreign affiliate performance. 
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The adjustment resulting from this formula is rather imprecise, as both parts of the 
assumption could be questioned.  To address the possibility that the resulting R&D entry 
components are inaccurate, alternative values of EF are also considered.  For foreign 
affiliates, along with the base case factor of 0.4, factors of 0.2 and 0.6 are used.  For U.S. 
parents, factors of 0.1 and 0.3 supplement the 0.2 base case factor.  For U.S. affiliates, 
alternative factors of 0.15 and 0.45 are used. 
The estimates of R&D capital provide a measure of one sort of intangible capital 
that could, in principle, be compared to similar measures of tangible capital.  However, 
due to the use of a real rate of depreciation (discussed in the second paragraph of this 
section), the R&D capital stock estimates are measured at current cost.  BEA’s surveys of 
MNC operations do collect data on the stock of property, plant, and equipment, but these 
are based on historical cost, not current cost.  A direct comparison would require 
conversion from one basis to another.  To go from current-cost to historical-cost R&D 
capital would rule out the use of the adjustment of depreciation rates for price changes 
discussed above.  Alternatively, to go from historical-cost to current-cost physical capital 
would most easily be accomplished by substituting the results of a perpetual inventory 
model for the values reported on BEA’s surveys.
63 
C)  Adjustment of value added estimates 
Compared to current estimation procedures, counting R&D spending as 
investment increases the computed value added of MNCs, by the amount of current-
period R&D investment (i.e., funding expenditures).  As currently estimated, MNC value 
added is computed as costs incurred (except those for intermediate inputs) plus profits 
earned in production (“profit-type return”).  Because current-period spending on R&D 
that had previously been expensed no longer counts against profits when the R&D is 
treated as investment, value added increases by the amount of new reported R&D 
spending (funding).  Depreciation of the R&D capital stock, on the other hand, now does 
count against profits where it previously had not, resulting in what would otherwise be a 
                                                 
63 This is something that is already done, though not published, at the aggregate 
level in the process of constructing current-cost estimates of the direct investment 
position. 
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partly or wholly offsetting reduction in profit-type return.
64  However, this reduction is 
itself exactly offset by the R&D depreciation-induced rise in the capital consumption 
allowance (a measure of depreciation based on the book value of depreciation and one of 
the components of costs).  Overall, therefore, the net effect is that profit-type return and 
value added both increase by the amount of R&D investment.  A numerical example that 
demonstrates these changes in the calculation of value added is provided in section B of 
the appendix. 
In the summary of the estimates that follows, value added is recomputed treating 
R&D as investment, and is compared to total U.S. private-industry GDP.  In addition, the 
value added of foreign affiliates is compared to that of U.S. parents.  As with the 
published value added estimates that treat R&D as an expense, annual estimates for 
majority-owned U.S. affiliates begin in 1988.
65   For foreign affiliates, annual estimates 
begin in 1982, with an additional estimate from the benchmark survey in 1977.
66   For 
U.S. parent companies, annual estimates begin in 1994, with earlier estimates from 
benchmark surveys in 1977, 1982, and 1989. 
                                                 
64 Both of these changes to profits cause “profits as reported by firms on surveys” 
to be defined differently than “profits as used in the value added calculation.”  If one 
preferred not to deal with these two separate “profit” estimates, an additional component 
could be added to the profit-type return category of value added.  This new component 
would equal current-year R&D investment net of current-year R&D depreciation.  It, 
along with income taxes and depletion less (net) capital gains and losses and income from 
equity investments, would be added to the net income reported on surveys to equal profit-
type return.  In section B of the appendix, this new component is termed “R&D 
investment adjustment.” 
65 Estimates of value added (termed “gross product” in the publications) were also 
published for 1977-87, but these estimates are for all U.S. affiliates (combining minority-
owned affiliates with majority-owned affiliates).  These all-affiliate estimates are not 
recomputed here. 
66 Estimates of foreign affiliates’ value added were published for 1966 and 1970, 
but are not recomputed here.  The former included all affiliates (not just majority-owned 
affiliates) and the latter estimated only value added growth for matched-samples, not the 
MNC universe levels of value added. 
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D)  Adjustment of direct investment earnings in ITA and IIP data 
The final step is to apply the results of the calculations on the MNC operations 
data detailed in steps 1-2 to the IIP estimates and the direct investment earnings values 
that feed into the ITAs and NIPAs.  In general, the outward investment ITA and IIP data 
are modified using the foreign affiliate operations data, and the inward investment ITA 
and IIP data are modified using the U.S. affiliate operations data.  Several data series can 
potentially be modified in this manner.  The following shows a selection of such series 
and describes, in broad terms, the type of modification used (the modifications 
themselves are subject to adjustments discussed below the table). 
Data series Initial year Modification      
                                                
Current-cost direct investment 
income  1966  Add current-year R&D spending less 
depreciation 
Investment income (includes 
income from portfolio investment)  1966  Add current-year R&D spending less 
depreciation 
Balance on current account   1966 
Add current-year foreign affiliate R&D 
spending less depreciation, subtract 
U.S. affiliate spending less depreciation 
Net rest-of-world corporate profits  1966 
Add current-year foreign affiliate R&D 
spending less depreciation, subtract 
U.S. affiliate spending less depreciation 
Direct investment position  1976  Add current-year R&D capital stock 
International investment position  1976  Add current-year R&D capital stock 
 
Differences in the scope and purpose of the MNC operations data compared to the 
ITA and IIP data may necessitate adjustments in order make the modifications detailed 
above.  There are two key issues.
67  First, the MNC R&D estimates pertain to majority-
owned affiliates while the ITA and IIP data pertain to all affiliates.  Second, the ITA and 
 
67 A third issue should be noted, as well.  The MNC operations estimates exclude 
companies classified in banking, while the balance of payments data include such 
companies.  Ignoring this issue is likely innocuous as—given the present definition of 
R&D—banking MNCs probably conduct very little R&D.  (NSF estimates for the entire 
U.S. economy combine banking with other finance, insurance, and real estate, but they 
show firms in this group—only a portion of which would be in banking—as accounting 
for only 0.8 percent of total funds for industrial R&D performance in 2004.) 
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IIP data, unlike the MNC R&D estimates, only include the parents’ share, or interest, in 
its affiliates.  Here it is assumed that a parent’s ownership of an individual affiliate’s 
assets is in the same proportion as its owners equity in the affiliate.  (Thus, a parent 
holding an 80 percent interest in an affiliate is, heuristically, assumed to “own” $400 of 
the affiliate’s $500 R&D capital stock.) 
The first issue—the inclusion of only majority-owned affiliates in MNC 
operations estimates—implies than in translating operations estimates to a basis 
consistent with ITA and IIP data, the MNC data should be scaled up.  The second issue—
the lack of scaling by the parents’ ownership shares in MNC operations estimates—
implies that the MNC data should be scaled down.  Although, in principle, the two issues 
imply separate adjustments (ones that likely vary both by year and type of investment), 
for simplicity, a rudimentary overall adjustment is used to approximate the net effect of 
the two issues.
68  The modification derived from MNC operations data (as detailed 
above) is multiplied by a composite scaling factor before adding it into the ITA and IIP 
data.  In the base case, the scaling factor is 1.00 for both inward and outward data, a 
particular situation in which the two implicit adjustments exactly offset each other.
69   
Two other alternative scaling factors are also considered, 0.85 and 1.15, cases in which 
one or the other of the implicit adjustments dominate.  Although data that would permit 
direct calculation of the scaling factors are not currently collected for either foreign or 
U.S. affiliates, for U.S. affiliates, the necessary data were collected for R&D investment 
in some prior years and—along with plausible hypotheticals such as the one described in 
section C of the appendix—have informed the selection of the scaling factors used.  In 
1997, for instance, unpublished data show that R&D investment, adjusted by ownership 
                                                 
68 Data are available that would allow the published values of current year R&D 
spending by majority-owned affiliates to be scaled for ownership shares with little 
trouble.  However, developing a methodology to carry these shares along each year in 
capital stock measures and depreciation measures would require substantial upfront work.  
An extension that accounted for minority-owned affiliates could not be directly computed 
from survey data; further assumptions are needed.  However, related data items that are 
collected on the operations survey might be used to guide year-by-year changes in 
estimates of minority-owned affiliates’ R&D investment. 
69 For an example motivating the choice of composite scaling factors, see section 
C in the appendix. 
  46   October  2007 
 
shares of all affiliates, was approximately 1.03 times the unadjusted investment by 
majority-owned affiliates, a value close to the base case scaling factor. 
E) Estimate summary 
i) Base case.  The figures and tables on the pages that follow give selected 
examples of the effects of treating R&D as investment on the MNC operations data series 
and on the ITA and IIP series.  Figure 1 shows base-case current-cost R&D capital stocks 
(also see table 1), as well as R&D expenditures and depreciation for U.S. parents, foreign 
affiliates, and U.S. affiliates.  In 2004, U.S. affiliates’ R&D capital stock was 20 percent 
higher than the stock of foreign affiliates; U.S. parents’ R&D capital stock was more than 
six times as high as that of foreign affiliates.  From 1966-2004, U.S. affiliates’ growth 
rates for these items were slightly higher than those for foreign affiliates.  Growth rates 
for U.S. parents were somewhat lower.  Annualized percentage growth rates of these 
items are shown in the tabulation below: 
Growth rates 







Foreign affiliates  10.5 10.7 10.7
U.S. parents  7.9 8.5 8.5
U.S. affiliates  10.6 12.1 12.2
 
Figures 2 and 3 show the effects of treating R&D as investment under the base-
case assumptions relative to current estimation methods (i.e, treating R&D as an expense) 
for several international accounts series.  Figure 2 shows inward and outward data 
separately for three series—direct investment income, the direct investment position, and 
the international investment position.  Figure 3 shows flow balances or net positions 
(outward estimates minus inward estimates) of six series—the three just named plus (all) 
international investment income, rest-of-world corporate profits, and the current account.  
In each graph in figures 2 and 3, estimates without R&D capitalization are shown with 
lines (solid or dashed) and estimates with R&D capitalization are shown with dots (solid 
or hollow).  For none of these series do the with- and without-capitalization series 
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diverge substantially.  Occasionally the changing the treatment of R&D causes the 
estimate to change signs, though only when the estimate itself is close to zero. 
The visual information in figures 1-3 is reinforced in a series of tables, tables 1-5.  
Tables 1-4 provide base-case time series for four key data items.  Table 1 gives R&D 
capital stocks and compares it to the total MNC nonfinancial capital stock.  This 
comparison is somewhat problematic for the U.S parent estimates, as the total capital 
stock measure combines two estimates measured on different bases—current-cost for 
R&D capital and historical-cost for (net) property, plant, and equipment.
70  Nonetheless, 
the comparison gives a rough idea of the relative sizes of the tangible and intangible 
capital stocks.  In 2004, under this comparison, the R&D capital stock of U.S. parents 
was 26 percent of total parent capital stock.  For foreign and U.S. affiliates, the 
corresponding shares were 11 percent.  Tables 2-4 compare estimates for MNC value 
added, direct investment income, and the direct investment position with and without 
R&D capitalization.  Treating R&D as investment raises the 2004 value added estimates 
for foreign affiliates by 3 percent, for U.S. parents by 7 percent, and for U.S. affiliates by 
6 percent.  Outward direct investment income in 2004 increases by 4 percent and inward 
direct investment income increases by 9 percent; the corresponding direct investment 
positions increase by 5 percent and 9 percent. 
Table 5 presents summary information for the time series of the items in tables 2-
4 and figures 2-3, comparing estimates produced without R&D capitalization to those 
produced with capitalization.  The first two columns compare growth rates.  Treating 
R&D as investment slightly increases two of the three value added growth rates, but it 
slightly decreases the growth rates of some of the other series.  Several of the growth 
rates are unchanged.  Growth rates are not shown for the balance items, as balances may 
be either positive or negative. 
                                                 
70 The use of an historical-cost estimate for physical capital likely results in an 
underestimate compared to the use a current-cost estimate.  The current-cost estimates 
used in table 1 for foreign affiliates and U.S. parents are informed by methods used for 
the IIP. 
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The third column of table 5 shows the median over each time series of the annual 
percentage difference between the two estimates (with vs. without capitalization—a 
positive value indicates that the with-capitalization value exceeds the without-
capitalization value).  The largest median relative differences—21 and 9 percent, 
respectively—are associated with inward direct investment income and the inward direct 
investment position.  For the income series in particular, this is due in part to small pre-
R&D-capitalization values.  Median differences for outward direct investment income 
and the outward direct investment position are smaller—4 percent and 7 percent, 
respectively.  Other differences, particularly those for balances, are closer to 1 to 2 
percent in absolute value.  These smaller differences, not surprisingly, are those 
associated with higher-level entries in the ITAs, the NIPAs, and international investment 
positions. 
The final two columns of table 5 show minimum and maximum annual 
percentage differences between the rival estimates.  For several of the series—
specifically, value added, outward direct investment income, and the outward and inward 
positions (both direct investment and international investment)—these extremes differ 
relatively little from the medians.  For the other series, the underlying estimates can be 
very close to, or cross, zero, an outcome that renders measures of percentage difference 
somewhat misleading.  As seen in figures 2 and 3, the relatively high minimum or 
maximum percentage differences shown in table 5 are not the result of large absolute 
differences. 
ii) Alternative assumptions.  Tables 6-9 are structured in a similar manner to table 
5, but instead of comparing estimates treating R&D as investment to estimates treating it 
as an expense, they compare base-case estimates to estimates using one of the alternative 
assumptions detailed in the previous discussion, with R&D treated as investment in 
both.
71   In turn, tables 6-9 show the effects of the alternative assumptions for 
                                                 
71 Compared to table 5, three of these tables add rows for the R&D capital stock 
and R&D depreciation.  These are not shown in table 5 because these items are 
meaningless unless R&D is treated as investment.  These tables also exclude value added 
rows, as value added estimates are invariant to these changes (because the alternative 
assumptions do not affect estimates of R&D investment).  Table 9 excludes R&D capital 
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depreciation, the entry factors, the level of the initial capital stocks, and adjustments for 
converting operations data to a basis consistent with international transactions and 
investment position data.
72  Of these, the effects of the depreciation alternatives generate 
the largest changes in the estimates, with typical divergences from the base case of 10-20 
percent for both R&D capital stock and R&D depreciation.  For other items, however, the 
effects are much smaller; only inward direct investment income has a median difference 
of greater than 2 percent. 
The effects of the alternative entry factors have only roughly half the effect of the 
depreciation alternatives.  Of all of the alternatives, the effects of varying the initial-year 
capital stocks are the smallest (focusing on the medians), barely even affecting the ITA 
and IIP measures.  The impact of the alternative adjustments in applying operations 
estimates to ITA and IIP data is slightly greater than the effect of the entry factor 
alternatives.  
Overall, the order-of-magnitude estimates presented here contain no great 
surprises.  It has long been observed that R&D is a greater relative part of MNCs’ U.S. 
activities than for the U.S. economy as a whole, a characteristic borne out in these 
estimates.  Compared to increases of current-dollar all-U.S. GDP due to the treatment of 
R&D as investment of nearly 3 percent reported in the 2007 domestic R&DSA, MNCs’ 
U.S. value added increases were larger: 4 percent to 7 percent for U.S. parents and 5 
percent to 6 percent for U.S. affiliates with the base case assumptions.  Foreign affiliates’ 
                                                                                                                                                 
stock and R&D depreciation, because changing assumptions about the adjustment from 
operations data to balance of payments data does not affect estimates of the operations 
data. 
72 Of potential interest, but not shown in these tables, is the effect of combining 
different sets of alternatives, rather than simply combining one alternative assumption 
with three other base-case assumptions.  Also not shown is the effect of applying 
different assumptions to different types of firms (foreign affiliate, U.S. parents, or U.S. 
affiliates).  For example, it might be argued that weaker intellectual protection regimes 
abroad result more rapid obsolescence of foreign R&D capital than of U.S. R&D capital, 
justifying, for example, an 18 percent depreciation rate for foreign affiliates and a 12 
percent rate for U.S. parents and U.S. affiliates.  Some of the effects of this situation can 
be gleaned by comparing the two panels in table 6, but the effect on balance items cannot 
be discerned. 
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value added increases were more similar to those shown in the domestic portion of the 
R&DSA. 
Changes in other variables of interest were also generally as anticipated.  Direct 
investment income changes, although not small, did not change the nature of these series.  
Other items, particularly balances and higher level ITA and IIP items, saw only marginal 
changes.  The alternative assumptions considered show that the general results are fairly 
robust.  Although the assumptions made in order to estimate the base case scenario are 
somewhat arbitrary, they do have some empirical basis, and the parameters used in 
generating the estimates can be varied somewhat around those assigned in the base case 
without changing the fundamental conclusions that can be drawn from the exercise. 
 
V.  Conclusions and recommendations 
This paper has examined a number of issues associated with the treatment of 
R&D as investment in the international accounts.  In addition, it has presented estimates 
of the effects of such a treatment on several key international data series.  BEA’s 
international R&D data come from two sources, surveys of international trade in services 
and intangible assets and surveys of the operations of MNCs.  R&D data from the 
surveys of trade in services and intangible assets are used to adjust measures of the 
domestic R&D capital stock.  R&D data from surveys on MNC operations can be used to 
adjust measures of internationally derived income, thus affecting the current account and 
IIP.  The operations R&D data are also of independent interest, allowing calculations of 
MNC R&D capital stocks and related measures. 
The treatment of R&D as investment is extended to account for internationally 
traded R&D in the main 2007 R&DSA.  Although certain data for earlier years were not 
collected (requiring extensive imputation), their effects on aggregate measures are 
relatively small, and the methodology for incorporating them into the R&DSA is 
relatively straightforward.  In contrast, the treatment of R&D as investment in data from 
surveys of MNC operations has yet to be incorporated into the main R&DSA.  
Consequently, such treatment is considered in this paper, which is a background paper 
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accompanying the 2007 R&DSA.  In many respects, the treatment of R&D as investment 
in these (operations) R&D data poses issues and problems similar to those faced for 
domestic R&D.  This paper describes a methodology for constructing MNC R&D capital 
stock estimates and presents results for several data series at the aggregate level up to 
2004 and beginning as early as 1966.  The estimates, although based in part on 
assumptions used to simplify the estimation procedure, show that, to a rough order of 
magnitude, the effects of treating R&D as investment in international data entering the 
ITAs and IIP are relatively minor.  Changes in the current account balance are typically 
on the order of 1 percent; changes in the balance of the international investment position 
are typically on the order of 2 percent. 
The order-of-magnitude estimates abstract from some important issues, however.  
Approaches to such issues as estimating depreciation or choosing appropriate price 
indexes should follow the R&DSA in structure, although practical problems may be more 
complex in some cases.  For other issues, the treatment of international R&D as 
investment is particularly challenging.  In measuring the R&D capital stock of MNCs, the 
issue of entry and exit must be confronted; this is simple conceptually, but existing data 
allow for only very rough estimates of entry effects.  Perhaps even more problematic is 
the issue of joint ownership.  With the boundary of MNCs overlapping the country 
boundaries used for economic accounting, and with non-rivalry in the use of R&D 
frustrating attempts to cleanly allocate the benefits of R&D among the various MNC 
entities, joint ownership is a conceptual hurdle without a clear answer. 
The paper has demonstrated that generating estimates of the effects of treating 
R&D as investment is feasible.  Using the order-of-magnitude estimates as a starting 
point, there are several actions that could increase the accuracy of R&D capital stocks.  
However, some of these would require substantial effort, particularly in terms of the up-
front work of resolving conceptual issues, identifying data, and designing methodologies.  
At a more basic level, if substantial importance were attached to developing rigorous and 
precise estimates in international R&D capital, BEA might wish to make changes to the 
type of R&D data it collects.  Most importantly, on the operations surveys, funding 
data—that are currently only collected in benchmark surveys—should be collected in 
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annual surveys.  On the international trade surveys, data should be collected in a way that 
allows for international transfers of ownership of R&D capital to be distinguished from 
international transactions in the rights to use such capital. 
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Appendix A:  R&D Definitions in BEA Surveys 
 
Annual data on trade in R&D services and intangible assets are collected on 
BEA’s BE-120 benchmark survey, conducted once every 5 years.
73  Quarterly data are 
collected on BEA’s BE-125 survey.  Prior to 2006 for annual data and 2007 for quarterly 
data, data were collected separately for transactions with unaffiliated persons and for 
those with affiliated persons.  For unaffiliated transactions, annual data were collected on 
the BE-22 survey and quarterly data were collected on the BE-25 survey.  For affiliated 
transactions, quarterly data were collected on the BE-577 and BE-605 surveys and annual 
data were collected once every 5 years on the BE-10 and BE-12 benchmark surveys. 
Survey instructions for the BE-120 and BE-125 define R&D and testing services 
as 
[c]ommercial and noncommercial research, product development services, and testing 
services. Includes fees for the conduct of experiments or performance of research and 
development activities aboard spacecraft. Excludes medical and dental laboratory 
services. 
These surveys instruct respondents than in reporting transactions in rights related 
to industrial processes and products, they should 
[i]nclude license fees, royalties, and other fees received or paid for the use, sale, or 
purchase of intangible assets, including patents, trade secrets, and other proprietary 
rights, that are used in connection with, or related to, the production of goods. (For 
example, include ‘maintenance’ fees paid to foreign governments for the continuation of 
patent rights.) If the charge for the process, design, etc., is subsumed in a contract for 
technical or professional services, the receipt or payment generally should be reported 
under the proper transaction number for that service. 
                                                 
73 BEA’s international surveys can be accessed on BEA’s Web site at 
<http://www.bea.gov/international/index.htm#surveys>. 
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Annual data on R&D expenditures of U.S. parents and foreign affiliates are 
collected on BEA’s BE-10 benchmark (financial and operating) survey, conducted once 
every 5 years.  For the intervening 4 years, annual data are collected on the BE-11 annual 
survey.  Annual data on R&D expenditures of U.S. affiliates of foreign companies are 
collected on BEA’s BE-12 benchmark survey, conducted once every 5 years.  For the 
intervening 4 years, annual data are collected on the BE-15 annual survey.  As a company 
might be both owned by a foreign parent company and have a foreign affiliate, there is 
some overlap between the U.S. parent data on the BE-10/11 surveys and the U.S. affiliate 
data on the BE-12/15 surveys. 
Following NSF, R&D is defined as comprising three distinct activities in 
instructions for MNC-operations survey respondents.  For example, the most recent 
benchmark survey of U.S. direct investment abroad defines R&D as one of the following: 
   Basic research is the pursuit of new scientific knowledge or understanding that does 
not have specific immediate commercial objectives, although it may be in fields of 
present or potential commercial interest. 
   Applied research applies the findings of basic research or other existing knowledge 
toward discovering new scientific knowledge that has specific commercial objectives 
with respect to new products, services, processes, or methods. 
   Development is the systematic use of the knowledge or understanding gained from 
research or practical experience directed toward the production or significant 
improvement of useful products, services, processes, or methods, including the design 
and development of prototypes, materials, devices, and systems. 
Despite this conceptual distinction, data are not collected separately for the three 
activities in BEA’s surveys of MNCs, only for R&D generally. 
Survey instructions direct respondents when reporting (performance) R&D 
expenditures to 
[i]nclude all costs incurred in performing R&D, including depreciation, amortization, 
wages and salaries, property taxes and other taxes (except income taxes), materials and 
supplies,  allocated overhead, and indirect costs. 
More specifically, they are instructed to  
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[i]nclude all costs incurred to support R&D. Include wages, salaries, and related costs; 
materials and supplies consumed; R&D depreciation, cost of computer software used in 
R&D activities; utilities, such as telephone, telex, electricity, water, and gas; travel costs 
and professional dues; property taxes and other taxes (except income taxes) incurred on 
account of the R&D organization or the facilities they use; insurance expenses; 
maintenance and repair, including maintenance of buildings and grounds; company 
overhead including: personnel, accounting, procurement and inventory, and salaries of 
research executives not on the payroll of the R&D organization. Exclude capital 
expenditures, expenditures for tests and evaluations once a prototype becomes a 
production model, patent expenses, and income taxes and interest. 
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Appendix B:  Supplementary Adjustment Information 
This appendix consists of three parts, each illustrating some aspect of the 
adjustments used to generate the order-of-magnitude estimates.  The first concerns the 
assumption regarding the relative contribution of the existing stock of new firms to the 
growth in MNC R&D capital stock versus that of the new stock of existing firms.  The 
second shows how value added increases when R&D is capitalized rather than expensed.  
The third clarifies reasons for adjusting MNC operations estimates to a basis consistent 
with the ITAs and IIP. 
(1)  Entry factor/components 
The following simplified example illustrates the source of the “entry factor” 
assumptions used in generating the order-of-magnitude estimates.  Consider a 
hypothetical foreign affiliate population consisting of 1,000 affiliates at the beginning of 
the year. 
Assumptions:  The beginning-of-year R&D capital stock is $500,000, an average 
of $500 of R&D capital per affiliate.  The stock depreciates at a rate of 10 percent, and 
new investment in R&D occurs at a rate of 15 percent (of the existing stock).  Over the 
course of the year, 60 firms are acquired or established as new foreign affiliates of U.S. 
parents, and 20 existing affiliates are sold to non-U.S. buyers.  The R&D capital stock of 
each the affiliates sold is the same, on average, as that of continuing affiliates—that is, 
$500. New firms come into the universe with an average capital R&D stock two-thirds 




Beginning of year stock  500,000  100%
Total change  35,000  7%
Investment net of depreciation  25,000  5%
Investment 75,000  15%
Depreciation (50,000) -10%
“Entry component”  10,000  2%
Entry 20,000  4%
Exit (10,000) -2%
End-of-year stock  535,000  107%
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Implications:  The change in capital can be decomposed as resulting from the 
following activities:  The total change in the R&D capital stock over the year is a $35,000 
(7-percent) increase, of which the “entry component” accounts for $10,000, or 0.286.  
(Note that the 0.286 factor is the R&D-capital counterpart to the physical-capital “entry 
factor” (EF) used in the order-of-magnitude calculations.)  Neither of these dollar 
increases can be computed in practice, as direct investment surveys do not collect 
information on the magnitude of R&D capital brought into the population for reasons 
other than investment.  However, data are available on the change in the physical capital 
stock (though on a historical-cost basis rather than current-cost basis), and (much noiser) 
data are available on the share due to the physical capital entry component.  The method 
used for the order-of magnitude estimates applies a rough, time-invariant estimate of the 
“entry factor” to data on changes in physical capital in hopes of accurately estimating the 
$15,000 entry component. 
A second type of entry and exit can be seen by adding additional assumptions:  
During the year, existing affiliates acquire 100 other firms in their own countries that 
were not previously foreign affiliates, and that become subsumed into their respective 
acquirers.  (In other words, the acquirees do not report separately on direct investment 
surveys, but their data is combined with that of their acquirers.)  These 100 firms, on 
average, have pre-acquisition R&D capital of $200.  In addition, existing affiliates sell off 
portions of their business 50 times during the year.  On average, the sold-off portions take 




Beginning of year stock  500,000  100%
Total change  40,000  8%
Investment net of depreciation  25,000  5%
Investment 75,000  15%
Depreciation (50,000) -10%
“Entry component”  15,000  3%
Entry 20,000  4%
Exit (10,000) -2%
Acquisitions by continuing affiliates  20,000  4%
Divestitures by continuing affiliates  (15,000) -3%
End-of-year stock  540,000  108%
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The implications of this slightly more complex example are qualitatively the same 
as in the first example.  The entry component, however, is $5,000 larger, at $20,000, with 
a correspondingly larger entry factor of 0.375. 
(2)  Value added calculations 
This section provides a simple three-firm example of value added calculation.  
Under existing methods, value added is computed as the sum of costs incurred (except for 
intermediate inputs) and profits earned in production.  Treating R&D as investment does 
not change this basic computation, but it does change how both costs and profits are 
calculated.  In the example, value added rises by the value of R&D funding expenditures 
(R&D investment), whether due to own-account R&D or to R&D purchased from an 
outside source. 
Assumptions:  In year 1, firms A and B each account for $100 of R&D 
performance.  Of the $100, $70 goes to compensate the researchers they employ and $30 
is for material (intermediate) inputs.  Firm A keeps its own R&D for itself, while firm B’s 
R&D is performed under contract (for $100) for firm C.  No other products are produced 
in year 1 and none of the firms possess any physical capital.  In year 2, firms A and C 
each utilize the resulting R&D capital along with $50 worth of labor services to produce 
output that is sold for $75.  No intermediate inputs or physical capital are used.  When 
R&D is treated as investment, the depreciation rate of R&D capital is assumed to be 15 
percent and, for simplicity, it is assumed that no depreciation occurs in the year in which 
the R&D is performed. 




  Year 1   Year 2    
 Firm    Firm 
  A B C    A B C 
R&D  performed  100  100 0  0  0  0 
Own-account  R&D  100 0  0  0  0  0 
R&D performed for others  0  100  0    0  0  0 
             
R&D funded  100  0  100    0  0  0 
Own-account  100 0  0  0  0  0 
Performed by others  0  0  100    0  0  0 
             
Value added with R&D expensed 
  Year 1   Year 2    
 Firm    Firm 
  A B C    A B C 
Employee  compensation  70  70 0    50 0 50 
             
Profit-type return  (100)  0  (100)    25  0  25 
Net income  (100)  0  (100)    25  0  25 
R&D investment adjustment  N/A  N/A  N/A    N/A  N/A  N/A 
             
Capital consumption 
allowances  0  0  0  0  0  0 
Physical capital depreciation  0  0  0    0  0  0 
R&D  capital  depreciation  0  0  0  0  0  0 
             
Value added  (30)  70  (100)    75  0  75 
MNC universe total      -60        150 
             
Value added with R&D treated as investment 
  Year 1   Year 2    
 Firm    Firm 
  A B C    A B C 
Employee  compensation  70  70 0    50 0 50 
             
Profit-type return  0  0  0    10  0  10 
Net income  (100)  0  (100)    25  0  25 
R&D investment adjustment  100  0  100    (15)  0  (15) 
             
Capital consumption 
allowances  0  0  0  0  0  0 
Physical capital depreciation  0  0  0    0  0  0 
R&D capital depreciation  0  0  0    15  0  15 
             
Value  added  70  70 0    75 0 75 
MNC universe total      140        150 
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Implications:  The second panel shows the value added calculation under the 
(current) expensing rules, and the third panel shows value added calculations with R&D 
treated as investment rather than as an expense.  Compared to the expensed R&D case, 
when R&D is treated as investment, value added increases by the sum of R&D employee 
costs in year 1 (the year in which the R&D is performed) and does not change in year 2 
(as depreciation of R&D capital exactly offsets lowered net income).  Note that the 
increase in value added applies whether R&D is performed for a firm’s own account or is 
purchased from another firm. 
(3)  Operations-data to international accounts-data scaling adjustment 
This section illustrates the two-part nature of the scaling adjustment used to 
convert R&D investment from published MNC operations data (or, more precisely, R&D 
investment derived from R&D expenditures published in MNC operations data) to a basis 
consistent with ITA and IIP data.  For MNC R&D data, estimates are currently published 
only for majority-owned affiliates, without adjusting for parents’ ownership shares of the 
affiliates in this group.  To convert the estimates for the operations data to the desired 
basis, ownership shares must be accounted for, and the estimates must be made to cover 
all affiliates (both majority-owned and minority-owned).  Unpublished data typically are 
available to adjust majority-owned affiliates’ estimates for ownership shares.  However, 
data for minority-owned affiliates—whether adjusted for ownership shares or not—
typically are not available. 
As discussed in the main text, the two reasons for making a scaling adjustment act 
in opposite directions; including minority-owned affiliates increases the estimate, but 
adjusting for ownership shares decreases it.  The following hypothetical example 
demonstrates these competing effects while also accounting for two empirical facts:  (a) 
in cases where data for all affiliates are available, estimates for majority-owned affiliates 
tend to be roughly 75-85 percent as high as the corresponding all-affiliate estimates; (b) 
large portions of the published majority-owned totals are typically accounted for by 
wholly-owned affiliates (foreign affiliates whose U.S. parent holds a 100 percent share in 
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the affiliate or U.S. affiliates whose foreign parent holds a 100 percent share).  In the 
example, the two implicit adjustments are almost exactly offsetting; the appropriate 
composite adjustment factor is very close to the assumed base-case factor of 1.00. 
Assumptions:  Three assumptions suffice to fully describe the data: 
(1) Majority-owned and minority-owned affiliates combine to invest $10,000 
in R&D. 
(2) Majority-owned affiliates account for 80 percent of R&D investment by 
affiliates.  As noted above, this percentage—although consistent with empirical fact 
(a)—is unknown in practice for R&D investment, as only the investment accounted for 
by majority-owned affiliates is reported on MNC surveys. 
(3) Parent-ownership shares (weighted by R&D investment) is uniformly 
distributed between 10 and 100 percent among those affiliates that are not wholly 
owned.  This assumption, while entirely hypothetical, is intended to be neutral—one in 
which R&D does not gravitate to a particular ownership structure (aside from one with 
complete parent ownership).  It is also intended to be simple; however, almost any 
distribution of R&D-weighted ownership shares that is symmetric about 50 percent 
would generate the essentially the same result. 
The following table summarizes these assumptions and some of the resulting 
implications. 







owned  Total 
1. Average parent-ownership share  100% 75% 30%   
2. R&D investment  5,500 2,500  2,000  10,000 
3. Majority-owned affiliate R&D 
investment  5,500  2,500       -  8,000 
4. Parent-ownership-share adjusted 
R&D investment  5,500 1,875   600  7,975 
5. Difference (row 3 minus row 4)       -   625  (600)   25 
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Implications:  Assumptions (1) and (2) imply that R&D investment by majority-
owned affiliates is $8,000 (the box around this value in the table indicates that this is 
known from the published operations data).  Minority-owned affiliates, therefore, account 
for $2,000 of R&D investment.  Assumption (3) implies that majority-owned affiliates 
that are not wholly owned account have an average parent-ownership share of 75 percent, 
and that minority-owned affiliates have an average parent-ownership share of 30 percent 
(given the 10-percent ownership threshold for direct investment).  Applying the 30 
percent share to the $2,000 of investment by minority-owned affiliates gives $600 as 
minority-owned affiliates’ portion of R&D investment scaled for consistency with the 
coverage of the ITAs.  Because minority-owned affiliates are not covered by the 
operations data, the $600 in R&D investment attributed to these affiliates in this example 
demonstrates the need for an upward scaling of the operations estimate. 
There is one other issue.  The operations data for majority-owned affiliates do not 
reflect parent ownership shares, as they must to be consistent with the coverage of the 
ITAs.  Therefore, the estimates of R&D investment for these affiliates must be adjusted 
to reflect ownership shares.  In practice, the affiliate-level operations data do permit 
direct computation of such an adjustment, though such an adjustment has, in the absence 
of R&D capitalization, not been previously needed or computed.  In this example, 
assumptions (1)-(3) do not show the necessary adjustment, but do provide enough 
information to compute it.  Specifically, the $8,000 operations estimate can be allocated 
between wholly-owned affiliates and those majority-owned affiliates that are not wholly 
owned.  Assumption (3), in combination with the $2,000 in R&D investment by 
minority-owned affiliates implies that R&D investment by majority-owned affiliates that 
are not wholly owned is $2,500.  Wholly-owned affiliates account for the remaining 
$5,500 of R&D investment.  With the 75 percent average parent-ownership share, the 
$2,500 in investment by majority-owned affiliates that are not wholly owned scales to 
$1,875 in ownership-adjusted R&D, $625 less than their contribution to the unadjusted 
estimate.  This $625 difference between majority-owned affiliates’ adjusted and 
unadjusted estimates demonstrates the need for the operations-data-based estimate to be 
scaled downwards. 
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The composite adjustment, of course, should account for the $600 needed 
increase along with the $625 needed decrease.  Together, the ideal adjustment would 
yield a $25 reduction compared to the original operations-data-based estimate.  Applying 
a scaling factor of 0.997—very close to the order-of-magnitude base-case adjustment of 
1.000—gives the true ownership-share adjusted total of $7,975. 
In this example, the decrease resulting from adjusting the operations-data-based 
estimate for majority-owned-affiliates for parents’ ownership shares almost exactly 
offsets the increase from adjusting the estimate for inclusion of minority-owned affiliates.  
Other hypothetical situations can be constructed that correspond to the 85 percent and the 
115 percent alternative composite adjustments used in the order-of-magnitude estimates, 
but to get far outside this range—given that majority-owned affiliates’ account for 
approximately 80 percent of non-adjusted activity by all affiliates—requires relatively 
implausible distributional assumptions. 
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Figure 1.  Selected International R&D Data with R&D Capitalization
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Figure 3. Comparison of Selected Flow Balances and Net Positions with and without 
R&D Capitalization
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1976 1978 1980 1982 1984 1986 1988 1990 1992 1994 1996 1998 2000 2002 2004




1966 2,617 37,191 1,948 7.1 …. ….
1967 3,016 41,895 2,220 …. …. ….
1968 3,492 47,246 2,515 …. …. ….
1969 4,040 53,125 2,826 …. …. ….
1970 4,659 59,433 3,149 …. …. ….
1971 5,331 65,876 3,465 …. …. ….
1972 6,043 72,246 3,764 …. …. ….
1973 6,909 79,829 4,111 …. …. ….
1974 8,096 90,416 4,594 …. …. ….
1975 9,447 101,934 5,091 …. …. ….
1976 10,624 110,648 5,432 …. …. ….
1977 12,000 120,566 5,811 6.1 20.5 6.4
1978 13,510 133,331 6,582 …. …. 6.0
1979 15,354 149,943 7,753 …. …. 5.6
1980 17,521 170,352 9,269 …. …. 5.3
1981 19,985 194,444 12,159 …. …. 4.9
1982 22,114 216,206 14,398 6.4 20.5 4.9
1983 23,499 231,130 16,013 6.9 …. 5.2
1984 24,750 246,556 17,941 7.9 …. 5.3
1985 26,965 261,360 19,959 8.5 …. 5.4
1986 29,191 275,288 21,945 8.8 …. 5.5
1987 32,145 291,933 24,530 9.0 …. 5.6
1988 35,407 311,756 28,636 9.0 …. 5.5
1989 39,397 333,935 33,794 9.1 22.8 5.6
1990 46,539 358,768 40,079 9.6 …. 5.6
1991 51,048 382,266 45,094 9.8 …. 5.8
1992 55,083 403,315 49,381 10.5 …. 7.4
1993 58,531 422,881 53,991 11.3 …. 7.6
1994 62,827 446,848 59,450 11.3 23.7 7.7
1995 67,447 475,529 66,286 11.0 …. 8.2
1996 71,691 503,912 72,646 10.8 …. 8.5
1997 74,993 534,576 79,077 10.7 …. 9.0
1998 79,490 566,287 91,490 10.3 …. 9.2
1999 86,668 608,503 102,858 10.2 23.4 9.4
2000 92,346 654,359 115,583 10.5 …. 9.6
2001 97,545 702,958 124,942 10.5 …. 9.8
2002 103,117 736,105 131,528 10.6 …. 10.1
2003 111,772 770,543 140,778 10.7 …. 10.5
2004 125,047 817,482 149,248 10.9 25.8 10.6
* Base case assumptions are used:
– Annual depreciation rate of R&D capital:  15%
– Entry factor (see text):  EF = {40% for foreign affiliates, 20% for U.S. parents, 30% for U.S. affiliates}
– Initial-year (1966) beginning-of-year capital stock:  4 times initial (1966) R&D expenditures
Source:  U.S. Bureau of Economic Analysis
2Total capital stock equals the net stock of property, plant, and equipment (valued at historical cost) plus the estimate of 
the net stock of R&D capital (valued at current cost).
Table 1.  R&D capital
Estimated stock (millions of current dollars) As share of total capital stock (percent)
1Total capital stock equals an unpublished estimate of the net stock of property, plant, and equipment plus the estimate 
of the net stock of R&D capital (both valued at current cost).
– Operations data scaled by factor of 1.00 to establish matching basis when used in modifying international 
transactions data (net effect of scaling up to convert from a majority-owned to an all-affiliate basis and scaling down to 
reflects parents' onwership share)Without R&DC With R&DC Without R&DC With R&DC Without R&DC With R&DC
1977 161,136 163,211 490,529 509,482 …. ….
1978 …. …. …. …. …. ….
1979 …. …. …. …. …. ….
1980 …. …. …. …. …. ….
1981 …. …. …. …. …. ….
1982 223,717 227,364 796,017 834,174 …. ….
1983 216,683 220,690 …. …. …. ….
1984 220,331 224,733 …. …. …. ….
1985 220,074 224,911 …. …. …. ….
1986 231,644 236,958 …. …. …. ….
1987 269,734 275,573 …. …. …. ….
1988 297,556 303,971 …. …. …. ….
1989 319,994 327,042 1,044,884 1,104,809 …. ….
1990 356,033 366,220 …. …. …. ….
1991 356,069 365,465 …. …. …. ….
1992 361,524 372,608 …. …. 214,781 225,526
1993 359,179 370,130 …. …. 223,008 234,270
1994 403,696 414,141 1,313,792 1,395,026 244,690 257,361
1995 465,576 476,456 1,365,470 1,453,551 254,938 269,784
1996 498,310 510,245 1,480,638 1,572,804 283,422 299,063
1997 520,867 533,059 1,573,451 1,672,921 313,655 330,262
1998 506,269 518,305 1,594,504 1,702,152 353,860 375,337
1999 566,396 581,022 1,914,343 2,035,695 397,295 420,244
2000 606,626 623,669 2,141,480 2,271,967 447,287 472,168
2001 585,657 602,603 1,892,399 2,030,495 417,122 442,146
2002 601,606 620,292 1,858,805 1,991,391 460,609 486,490
2003 697,778 718,189 1,958,125 2,093,853 475,062 503,103
2004 824,336 850,245 2,215,800 2,364,015 511,474 539,607
R&DC: R&D capitalization
Data are in millions of current dollars, base case assumptions are used.
* Base case assumptions:
– Annual depreciation rate of R&D capital:  15%
– Entry factor (see text):  EF = {40% for foreign affiliates, 20% for U.S. parents, 30% for U.S. affiliates}
– Initial-year (1966) beginning-of-year capital stock:  4 times initial (1966) R&D expenditures
Source:  U.S. Bureau of Economic Analysis
– Operations data scaled by factor of 1.00 to establish matching basis when used in modifying international 
transactions data (for details, see note to table 1)
U.S. parents
Table 2.  Value added
U.S. affiliates Foreign affiliatesWithout R&DC With R&DC Without R&DC With R&DC Without R&DC With R&DC
1966 5,260 5,517 711 902 4,549 4,615
1967 5,603 5,892 821 1,005 4,782 4,887
1968 6,591 6,939 876 1,071 5,715 5,868
1969 7,649 8,050 848 1,046 6,801 7,003
1970 8,169 8,617 875 1,070 7,294 7,547
1971 9,160 9,635 1,164 1,339 7,996 8,296
1972 10,949 11,436 1,284 1,427 9,665 10,009
1973 16,542 17,152 1,610 1,787 14,932 15,365
1974 19,157 20,053 1,331 1,629 17,826 18,424
1975 16,595 17,603 2,234 2,542 14,361 15,061
1976 18,999 19,777 3,110 3,242 15,889 16,535
1977 19,673 20,600 2,834 2,991 16,839 17,610
1978 25,458 26,569 4,211 4,575 21,247 21,995
1979 38,183 39,579 6,357 6,983 31,826 32,596
1980 37,146 38,803 8,635 9,488 28,511 29,315
1981 32,549 34,431 6,898 8,500 25,651 25,931
1982 29,469 30,934 2,114 3,652 27,355 27,283
1983 31,750 32,942 4,120 5,490 27,630 27,452
1984 35,325 36,709 8,443 10,007 26,882 26,701
1985 35,410 36,819 6,945 8,523 28,465 28,296
1986 36,938 38,304 6,856 8,440 30,082 29,864
1987 46,288 47,966 7,676 9,614 38,612 38,352
1988 58,445 60,500 12,150 14,823 46,295 45,677
1989 61,981 64,327 7,045 10,500 54,936 53,827
1990 65,973 70,787 3,450 7,820 62,523 62,967
1991 58,718 61,862 -2,265 1,539 60,983 60,322
1992 57,539 61,223 2,190 6,351 55,349 54,873
1993 67,245 70,280 7,943 12,002 59,302 58,278
1994 77,344 79,203 22,150 26,812 55,194 52,391
1995 95,260 96,870 30,318 36,239 64,942 60,631
1996 102,505 104,446 33,093 38,772 69,412 65,674
1997 115,323 116,819 42,950 48,504 72,373 68,315
1998 103,963 104,304 38,418 46,990 65,545 57,314
1999 131,626 133,943 53,437 62,011 78,189 71,932
2000 151,839 156,288 56,910 66,410 94,929 89,878
2001 128,665 132,454 12,783 21,154 115,882 111,300
2002 145,590 149,734 43,244 50,561 102,346 99,173
2003 186,417 191,638 73,750 82,583 112,667 109,055
2004 239,008 249,000 99,600 108,290 139,408 140,710
R&DC: R&D capitalization
Data are in millions of current dollars, base case assumptions are used.
* Base case assumptions:
– Annual depreciation rate of R&D capital:  15%
– Entry factor (see text):  EF = {40% for foreign affiliates, 20% for U.S. parents, 30% for U.S. affiliates}
– Initial-year (1966) beginning-of-year capital stock:  4 times initial (1966) R&D expenditures
Source:  U.S. Bureau of Economic Analysis
– Operations data scaled by factor of 1.00 to establish matching basis when used in modifying international 
transactions data (for details, see note to table 1)
Table 3.  Current-cost direct investment income
Balance (outward minus inward) Outward investment Inward investmentWithout R&DC With R&DC Without R&DC With R&DC Without R&DC With R&DC
1976 222,283 232,907 47,528 52,960 174,755 179,947
1977 246,078 258,078 55,413 61,224 190,665 196,854
1978 285,005 298,515 68,976 75,558 216,029 222,956
1979 336,301 351,655 88,579 96,332 247,722 255,324
1980 388,072 405,593 127,105 136,374 260,967 269,219
1981 407,804 427,789 164,623 176,782 243,181 251,006
1982 374,059 396,173 184,842 199,240 189,217 196,932
1983 355,643 379,142 193,708 209,721 161,935 169,422
1984 348,342 373,092 223,538 241,479 124,804 131,613
1985 371,036 398,001 247,223 267,182 123,813 130,819
1986 404,818 434,009 284,701 306,646 120,117 127,363
1987 478,062 510,207 334,552 359,082 143,510 151,125
1988 513,761 549,168 401,766 430,402 111,995 118,766
1989 553,093 592,490 467,886 501,680 85,207 90,810
1990 616,655 663,194 505,346 545,425 111,309 117,768
1991 643,364 694,412 533,404 578,498 109,960 115,914
1992 663,830 718,913 540,270 589,651 123,560 129,262
1993 723,526 782,057 593,313 647,304 130,213 134,753
1994 786,565 849,392 617,982 677,432 168,583 171,960
1995 885,506 952,953 680,066 746,352 205,440 206,601
1996 989,810 1,061,501 745,619 818,265 244,191 243,236
1997 1,068,063 1,143,056 824,136 903,213 243,927 239,843
1998 1,196,021 1,275,511 920,044 1,011,534 275,977 263,976
1999 1,414,355 1,501,023 1,101,709 1,204,567 312,646 296,456
2000 1,531,607 1,623,953 1,421,017 1,536,600 110,590 87,354
2001 1,693,131 1,790,676 1,518,473 1,643,415 174,658 147,261
2002 1,867,043 1,970,160 1,499,952 1,631,480 367,091 338,680
2003 2,054,464 2,166,236 1,580,994 1,721,772 473,470 444,464
2004 2,463,608 2,588,655 1,742,246 1,891,494 721,362 697,161
R&DC: R&D capitalization
Data are in millions of current dollars, base case assumptions are used.
* Base case assumptions:
– Annual depreciation rate of R&D capital:  15%
– Entry factor (see text):  EF = {40% for foreign affiliates, 20% for U.S. parents, 30% for U.S. affiliates}
– Initial-year (1966) beginning-of-year capital stock:  4 times initial (1966) R&D expenditures
Source:  U.S. Bureau of Economic Analysis
Net
– Operations data scaled by factor of 1.00 to establish matching basis when used in modifying international 
transactions data (for details, see note to table 1)
Outward Inward
Table 4.  Direct investment position at current costA )
Table 5.  Comparisons of International Data with and without R&D Capitalization
Base case assumptions*
Annualized growth rate 
(percent)
Percent difference between annual estimates: With-R&DC vs. 
without-R&DC
Without R&DC With R&DC Median Minimum Maximum
Value added
Foreign affiliates 7.4 7.5 2.4 1.3 3.1
U.S. parents 5.4 5.4 6.3 3.9 7.3
U.S. affiliates 7.7 7.7 5.6 5.0 6.1
Current-cost direct investment income
Outward investment 10.6 10.5 4.1 0.3 7.3
Inward investment 13.9 13.4 21.0 -168.0 190.0
Balance …. …. -0.6 -12.6 4.9
ITA balance on investment income …. …. -0.5 -193.0 5.5
ITA balance on current account …. …. 1.2 -270.3 50.7
Rest-of-world corporate profits (balance) …. …. -0.4 -8.0 4.8
Direct investment position
Outward investment 9.0 9.0 6.6 4.5 8.3
Inward investment 13.7 13.6 8.6 7.1 11.4
Balance …. …. 3.2 -21.0 6.6
International investment position
Outward investment 11.3 11.3 2.0 1.4 2.4
Inward investment 14.0 14.0 1.6 1.3 1.9
Balance …. …. 1.4 -20.0 12.9
Percent in 2004 nnual difference: With-R&DC vs. without-R&DC (percentage point
Addenda:  Value added shares Without R&DC With R&DC Median Minimum Maximum
Foreign affiliates in U.S. MNC total 27.1 26.5 -0.70 -0.76 -0.54
U.S. parents in U.S. private industry 
GDP 25.0 26.7 1.65 1.52 1.80
U.S. affiliates in U.S. private industry 
GDP 5.8 6.1 0.32 0.22 0.34
ITA:  International transactions accounts
R&DC:  R&D capitalization
Notes:
-- Series switching from positive to negative values, or series with values close to zero, are subject to large percentage differences even 
when absolute differences are small, due to the small denominator used in the calculation.  This is primarily, but not exclusively, an issue with 
"balance series."  Percentage differences of series for which this might occur are shown in italics.
-- Annualized growth rate are the percent change, at annual rates, from the earliest year for which estimates are made to 2004.
* Base case assumptions:
– Annual depreciation rate of R&D capital:  15%
– Entry factor (see text):  EF = {40% for foreign affiliates, 20% for U.S. parents, 30% for U.S. affiliates}
– Initial-year (1966) beginning-of-year capital stock:  4 times initial (1966) R&D expenditures
– Operations data scaled by factor of 1.00 to establish matching basis when used in modifying international transactions data (for details, 
see note to table 1)
Source:  U.S. Bureau of Economic Analysis
Source:  U.S. Bureau of Economic AnalysisTable 6.  Comparisons of Depreciation Alternatives to Base Case
Base case:  Depreciation rate of 15% for R&D capital stock
Alternative:  Depreciation rate of 12% for R&D capital stock
Annualized growth rate (percent) Annual difference from base case (percent)
Base case Alternative Median Minimum Maximum
R&D capital stock
Foreign affiliates 10.7 11.2 21.3 3.1 23.7
U.S. parents 8.5 9.0 21.7 3.1 22.9
U.S. affiliates 11.4 12.5 18.6 3.1 23.4
R&D depreciation
Foreign affiliates 10.7 11.3 -11.8 -38.4 -4.8
U.S. parents 8.5 9.1 -11.4 -38.4 -5.4
U.S. affiliates 11.6 12.6 -13.2 -36.9 -8.8
Current-cost direct investment income
Outward investment 10.5 10.5 1.0 0.5 1.5
Inward investment 13.3 13.3 3.6 2.1 46.9
Balance …. …. 0.2 -1.1 0.9
ITA balance on investment income …. …. 0.3 -9.9 14.6
ITA balance on current account …. …. 0.2 -3.9 40.9
Rest-of-world corporate profits (balance) …. …. 0.2 -0.7 0.8
Direct investment position
Outward investment 9.0 9.0 1.4 0.8 1.6
Inward investment 13.5 13.6 1.6 1.3 2.2
Balance …. …. 1.1 -0.1 2.4
International investment position
Outward investment 11.3 11.3 0.4 0.3 0.5
Inward investment 14.0 14.0 0.3 0.2 0.4
Balance …. …. -0.1 -6.8 2.9
Alternative:  Depreciation rate of 18% for R&D capital stock
Annualized growth rate (percent) Annual difference from base case (percent)
Base case Alternative Median Minimum Maximum
R&D capital stock
Foreign affiliates 10.7 10.3 -15.6 -16.8 -3.1
U.S. parents 8.5 8.1 -15.9 -16.3 -3.1
U.S. affiliates 11.4 11.7 -13.9 -17.6 -3.1
R&D depreciation
Foreign affiliates 10.7 10.2 8.1 3.0 28.8
Source:  U.S. Bureau of Economic Analysis 8.5 8.1 7.7 3.9 28.1
U.S. affiliates 11.6 11.8 10.1 6.7 25.7
Current-cost direct investment income
Outward investment 10.5 10.6 -0.7 -1.5 -0.3
Inward investment 13.3 13.6 -2.5 -36.1 -1.4
Balance …. …. -0.1 -0.7 1.0
ITA balance on investment income …. …. -0.1 -13.4 9.0
ITA balance on current account …. …. -0.2 -31.4 3.3
Rest-of-world corporate profits (balance) …. …. -0.1 -0.6 0.6
Direct investment position
Source:  U.S. Bureau of Economic Analysis 9.0 9.0 -1.0 -1.2 -0.6
Inward investment 13.5 13.6 -1.2 -1.7 -0.9
Balance …. …. -0.6 -1.7 0.6
International investment position
Outward investment 11.3 11.3 -0.3 -0.4 -0.2
Inward investment 14.0 14.0 -0.2 -0.3 -0.2
Balance …. …. 0.0 -2.2 5.0
ITA:  International transactions accounts
* Denotes a value greater than 0 percent, but less than 0.05 percent in absolute value.
Notes:
-- Series switching from positive to negative values, or series with values close to zero, are subject to large percentage differences even 
when absolute differences are small, due to the small denominator used in the calculation.  This is primarily, but not exclusively, an 
issue with "balance series."  Percentage differences of series for which this might occur are shown in  italics .
-- Annualized growth rate are the percent change, at annual rates, from the earliest year for which estimates are made to 2004.
Source:  U.S. Bureau of Economic Analysiss
s
a
Table 7.  Comparisons of Entry Factor Alternatives to Base Case
1
Base case:  Entry factors of 40% (foreign affiliates), 20% (U.S. parents), 30% (U.S. affiliates)
Alternative:  Entry factors of 20% (foreign affiliates), 10% (U.S. parents), 15% (U.S. affiliates)
Annualized growth rate (percent) Annual difference from base case (percent)
Base case Alternative Median Minimum Maximum
R&D capital stock
Foreign affiliates 10.7 10.5 -7.2 -9.8 0.0
U.S. parents 8.5 8.4 -3.0 -5.6 0.0
U.S. affiliates 11.4 12.0 -7.4 -15.0 0.0
R&D depreciation
Foreign affiliates 10.7 10.5 -7.5 -9.4 0.0
U.S. parents 8.5 8.5 -3.1 -6.2 0.0
U.S. affiliates 11.6 12.1 -7.5 -17.2 0.0
Current-cost direct investment income
Outward investment 10.5 10.6 0.6 0.0 0.9
Inward investment 13.3 13.4 1.7 0.0 31.2
Balance …. …. 0.1 -0.2 0.7
ITA balance on investment income …. …. 0.1 -9.8 5.6
ITA balance on current account …. …. 0.0 -0.7 4.7
Rest-of-world corporate profits (balance) …. …. 0.1 -0.1 0.4
Direct investment position
Outward investment 9.0 9.0 -0.4 -0.6 -0.3
Inward investment 13.5 13.7 -0.6 -1.0 -0.2
Balance …. …. -0.2 -2.1 0.4
International investment position
Outward investment 11.3 11.3 -0.1 -0.2 -0.1
Inward investment 14.0 14.0 -0.1 -0.3 0.0
Balance …. …. 0.1 -0.2 0.5
Alternative:  Entry factors of 60% (foreign affiliates), 30% (U.S. parents), 45% (U.S. affiliates)
Annualized growth rate (percent) Annual difference from base case (percent)
Base case Alternative Median Minimum Maximum
R&D capital stock
Foreign affiliates 10.7 10.9 8.3 0.0 11.5
U.S. parents 8.5 8.5 3.2 0.0 6.2
U.S. affiliates 11.4 12.2 8.3 0.0 18.9
R&D depreciation
Foreign affiliates 10.7 10.9 8.8 0.0 11.1
Source:  U.S. Bureau of Economic Analysi 8.5 8.6 3.4 0.0 6.8
U.S. affiliates 11.6 12.2 9.1 0.0 21.7
Current-cost direct investment income
Outward investment 10.5 10.5 -0.6 -1.1 0.0
Inward investment 13.3 13.4 -2.0 -38.5 0.0
Balance …. …. -0.1 -0.8 0.3
ITA balance on investment income …. …. -0.1 -6.9 11.5
ITA balance on current account …. …. 0.0 -4.5 0.7
Rest-of-world corporate profits (balance) …. …. -0.1 -0.5 0.2
Direct investment position
Source:  U.S. Bureau of Economic Analysi 9.0 9.0 0.5 0.4 0.7
Inward investment 13.5 13.6 0.7 0.2 1.3
Balance …. …. 0.2 -0.6 2.9
International investment position
Outward investment 11.3 11.3 0.2 0.1 0.2
Inward investment 14.0 14.0 0.1 0.0 0.3
Balance …. …. -0.2 -0.9 0.8
ITA:  International transactions accounts
* Denotes a value greater than 0 percent, but less than 0.05 percent in absolute value.
1The entry factor is one part of an assumption about that portion of the change in the R&D capital stock due to entry and exit of entities 
plus acquisitions and divestitures by continuing entities.  Specifically, the entry factor is the share of the assumed change in the stock of 
physical capital due to these four types of transactions.  Multiplying this factor by the percentage change in the stock of physical capital 
and by the prior year R&D capital stock gives the entry component of the change in the R&D capital stock.
Notes:
-- Series switching from positive to negative values, or series with values close to zero, are subject to large percentage differences 
even when absolute differences are small, due to the small denominator used in the calculation.  This is primarily, but not exclusively, 
issue with "balance series."  Percentage differences of series for which this might occur are shown in  italics.
-- Annualized growth rate are the percent change, at annual rates, from the earliest year for which estimates are made to 2004.
Source:  U.S. Bureau of Economic AnalysisTable 8.  Comparisons of Initial R&D Capital Stock Alternatives to Base Case
Base case:  Initial R&D capital stock of 4.0 times initial R&D expenditures
Alternative:  Initial R&D capital stock of 2.5 times initial R&D expenditures
Annualized growth rate (percent) Annual difference from base case (percent)
Base case Alternative Median Minimum Maximum
R&D capital stock
Foreign affiliates 10.7 11.7 -0.8 -29.6 0.0
U.S. parents 8.5 9.5 -0.9 -29.6 0.0
U.S. affiliates 11.4 13.1 -1.0 -29.6 0.0
R&D depreciation
Foreign affiliates 10.7 11.9 -0.8 -33.4 0.0
U.S. parents 8.5 9.7 -1.0 -33.4 0.0
U.S. affiliates 11.6 13.4 -1.2 -33.4 0.0
Current-cost direct investment income
Outward investment 10.5 10.5 0.1 0.0 2.0
Inward investment 13.3 13.2 0.3 0.0 9.2
Balance …. …. 0.0 0.0 0.6
ITA balance on investment income …. …. 0.0 0.0 0.6
ITA balance on current account …. …. 0.0 -1.4 3.0
Rest-of-world corporate profits (balance) …. …. 0.0 0.0 0.6
Direct investment position
Outward investment 9.0 9.0 0.0 -0.2 0.0
Inward investment 13.5 13.6 0.0 -0.6 0.0
Balance …. …. 0.0 -0.1 0.0
International investment position
Outward investment 11.3 11.3 0.0 -0.1 0.0
Inward investment 14.0 14.0 0.0 -0.1 0.0
Balance …. …. 0.0 -0.1 0.0
Alternative:  Initial R&D capital stock of 7.0 times initial R&D expenditures
Annualized growth rate (percent) Annual difference from base case (percent)
Base case Alternative Median Minimum Maximum
R&D capital stock
Foreign affiliates 10.7 9.4 1.5 0.0 59.1
U.S. parents 8.5 7.2 1.8 0.0 59.1
U.S. affiliates 11.4 10.7 2.1 0.0 59.1
R&D depreciation
Foreign affiliates 10.7 9.2 1.7 0.1 66.8
Source:  U.S. Bureau of Economic Analysis 8.5 7.1 1.9 0.1 66.8
U.S. affiliates 11.6 10.7 2.3 0.0 66.8
Current-cost direct investment income
Outward investment 10.5 10.7 -0.1 -4.0 0.0
Inward investment 13.3 14.0 -0.6 -18.4 0.0
Balance …. …. 0.0 -1.2 0.0
ITA balance on investment income …. …. 0.0 -1.1 0.0
ITA balance on current account …. …. 0.0 -6.0 2.7
Rest-of-world corporate profits (balance) …. …. 0.0 -1.2 0.0
Direct investment position
Source:  U.S. Bureau of Economic Analysis 9.0 9.0 0.0 0.0 0.3
Inward investment 13.5 13.6 0.0 0.0 1.2
Balance …. …. 0.0 0.0 0.1
International investment position
Outward investment 11.3 11.3 0.0 0.0 0.2
Inward investment 14.0 14.0 0.0 0.0 0.2
Balance …. …. 0.0 0.0 0.1
ITA:  International transactions accounts
* Denotes a value greater than 0 percent, but less than 0.05 percent in absolute value.
Notes:
-- Series switching from positive to negative values, or series with values close to zero, are subject to large percentage differences even 
when absolute differences are small, due to the small denominator used in the calculation.  This is primarily, but not exclusively, an 
issue with "balance series."  Percentage differences of series for which this might occur are shown in  italics .
-- Annualized growth rate are the percent change, at annual rates, from the earliest year for which estimates are made to 2004.
Source:  U.S. Bureau of Economic Analysiss
Table 9.  Comparisons of Alternatives in Modifying International Transactions Data with 
Operations Data
Base case:  Operations data scaled by factor of 1.00 to match basis of international transactions data
Alternative:  Operations data scaled by factor of 0.85 to match basis of international transactions data
Annualized growth rate (percent) Annual difference from base case (percent)
Base case Alternative Median Minimum Maximum
Current-cost direct investment income
Outward investment 10.5 10.5 -0.6 -1.0 0.0
Inward investment 13.3 13.5 -2.7 -37.1 -0.6
Balance …. …. 0.1 -0.7 2.2
ITA balance on investment income …. …. 0.0 -31.1 12.3
ITA balance on current account …. …. -0.2 -23.8 4.4
Rest-of-world corporate profits (balance) …. …. 0.1 -0.7 1.3
Direct investment position
Outward investment 9.0 9.0 -0.9 -1.1 -0.6
Inward investment 13.5 13.6 -1.2 -1.5 -1.0
Balance …. …. -0.5 -0.9 4.0
International investment position
Outward investment 11.3 11.3 -0.3 -0.3 -0.2
Inward investment 14.0 14.0 -0.2 -0.3 -0.2
Balance …. …. -0.2 -1.7 3.8
Alternative:  Operations data scaled by factor of 1.15 to match basis of international transactions data
Annualized growth rate (percent) Annual difference from base case (percent)
Base case Alternative Median Minimum Maximum
Current-cost direct investment income
Outward investment 10.5 10.5 0.6 0.0 1.0
Inward investment 13.3 13.4 2.7 0.6 37.1
Balance …. …. -0.1 -2.2 0.7
ITA balance on investment income …. …. 0.0 -12.3 31.1
ITA balance on current account …. …. 0.2 -4.4 23.8
Rest-of-world corporate profits (balance) …. …. -0.1 -1.3 0.7
Direct investment position
Outward investment 9.0 9.0 0.9 0.6 1.1
Inward investment 13.5 13.6 1.2 1.0 1.5
Balance …. …. 0.5 -4.0 0.9
International investment position
Outward investment 11.3 11.3 0.3 0.2 0.3
Inward investment 14.0 14.0 0.2 0.2 0.3
Source:  U.S. Bureau of Economic Analysi …. …. 0.2 -3.8 1.7
ITA:  International transactions accounts
* Denotes a value greater than 0 percent, but less than 0.05 percent in absolute value.
Notes:
-- Series switching from positive to negative values, or series with values close to zero, are subject to large percentage differences even
when absolute differences are small, due to the small denominator used in the calculation.  This is primarily, but not exclusively, an 
issue with "balance series."  Percentage differences of series for which this might occur are shown in  italics.
-- Annualized growth rate are the percent change, at annual rates, from the earliest year for which estimates are made to 2004.
Source:  U.S. Bureau of Economic Analysis